| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | NCAPD3 XRCC1 KMT2E BPTF BRD2 ATRIP PHF20L1 SPIN2A KMT2A SPIN2B | 9.51e-06 | 206 | 167 | 10 | GO:0140030 |
| GeneOntologyMolecularFunction | histone binding | NPM1 NCAPD3 KMT2E BPTF PHC3 BRD2 SPIN2A SMARCC1 KMT2A SPIN2B | 8.14e-05 | 265 | 167 | 10 | GO:0042393 |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 9.62e-05 | 88 | 167 | 6 | GO:0140034 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 7.53e-07 | 66 | 159 | 7 | GO:0007019 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.04e-05 | 38 | 159 | 5 | GO:0007026 | |
| GeneOntologyBiologicalProcess | DNA repair | NPM1 PDS5B EXOSC10 ERCC6 XPC XRCC1 RFC1 PTTG3P ARID1B ATRIP ATXN7 MORF4L2 DYRK1B SMARCC1 TAF6 POLK PTTG2 | 1.12e-05 | 648 | 159 | 17 | GO:0006281 |
| GeneOntologyBiologicalProcess | cell cycle process | NUSAP1 NPM1 PDS5B UBR2 NCAPD3 ERCC6 PRICKLE1 AHCTF1 BRSK2 APC BBS4 YTHDC2 XPC KMT2E CHAMP1 PTTG3P ARID1B LATS2 ATRIP ANLN CEP44 BUB1 SMARCC1 KIF2A CSPP1 MN1 PTTG2 | 1.48e-05 | 1441 | 159 | 27 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA damage response | NPM1 PDS5B EXOSC10 ERCC6 RBBP6 APC XPC XRCC1 RFC1 PTTG3P ARID1B ATRIP NFATC2 ATXN7 MORF4L2 DYRK1B SMARCC1 TAF6 POLK MNDA PTTG2 | 1.57e-05 | 959 | 159 | 21 | GO:0006974 |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 1.73e-05 | 42 | 159 | 5 | GO:0031114 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 4.51e-05 | 51 | 159 | 5 | GO:0031111 | |
| GeneOntologyBiologicalProcess | chromatin organization | NPM1 UBR2 ERCC6 ZDBF2 KMT2E TDRD1 TTF1 MBD3 HP1BP3 BPTF RCOR1 ARID1B BRD2 MORF4L2 BUB1 SMARCC1 KMT2A ZNF518B DNMT1 | 6.32e-05 | 896 | 159 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromosome organization | NUSAP1 PDS5B NCAPD3 EXOSC10 GNL3L PRICKLE1 APC XRCC1 RFC1 CHAMP1 PTTG3P ARID1B BUB1 SMARCC1 KIF2A PTTG2 | 8.34e-05 | 686 | 159 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | NPM1 UBR2 ERCC6 ZDBF2 KMT2E TDRD1 TTF1 MBD3 HP1BP3 BPTF RCOR1 ARID1B BRD2 MORF4L2 BUB1 SMARCC1 KMT2A ZNF518B TAF6 DNMT1 | 8.83e-05 | 999 | 159 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | DNA metabolic process | NPM1 PDS5B UBR2 EXOSC10 GNL3L ERCC6 RBBP6 XPC XRCC1 RFC1 TTF1 PTTG3P ARID1B ATRIP ATXN7 MORF4L2 DYRK1B SMARCC1 TAF6 POLK PTTG2 | 8.89e-05 | 1081 | 159 | 21 | GO:0006259 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | NUSAP1 NCAPD3 PRICKLE1 APC CHAMP1 PTTG3P ARID1B BUB1 SMARCC1 KIF2A PTTG2 | 1.03e-04 | 356 | 159 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | NPM1 EXOSC10 GNL3L MAP1A APC BBS4 XRCC1 DLC1 ATXN7 BUB1 CAMSAP1 CAMSAP2 | 1.07e-04 | 421 | 159 | 12 | GO:0010639 |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.29e-04 | 144 | 159 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 1.34e-04 | 194 | 159 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.62e-04 | 254 | 159 | 9 | GO:0000819 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 1.65e-04 | 36 | 159 | 4 | GO:0007064 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | NPM1 UBR2 ERCC6 ZDBF2 KMT2E TDRD1 TTF1 MBD3 HP1BP3 BPTF ARID1B BRD2 BUB1 SMARCC1 KMT2A DNMT1 | 2.02e-04 | 741 | 159 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 3.32e-04 | 168 | 159 | 7 | GO:0031109 | |
| GeneOntologyCellularComponent | nuclear speck | CBLL1 NPM1 ATXN2L AFF2 BMP2K RBBP6 KMT2E TOE1 HP1BP3 SART1 BRD2 PIAS3 RBM19 ZNF638 MNDA | 1.40e-06 | 431 | 162 | 15 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | EXOSC10 GNL3L ERCC6 AFF2 SYNE1 AHCTF1 GPATCH1 XPC XRCC1 RBM28 KMT2E ZC3H3 MBD3 COPS7A SART1 BPTF PHC3 RCOR1 ARID1B NOP14 ATRIP NFATC2 ATXN7 SMARCC1 KMT2A TAF6 | 2.13e-05 | 1377 | 162 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | CBLL1 NPM1 ATXN2L ERCC6 AFF2 BMP2K RBBP6 AHCTF1 KMT2E CHAMP1 TOE1 HP1BP3 SART1 BRD2 PIAS3 RBM19 ZNF638 KIF2A POLK MNDA | 2.36e-05 | 903 | 162 | 20 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | PDS5B UBR2 NCAPD3 SP4 EXOSC10 ERCC6 MAGED1 AHCTF1 TRPS1 XPC XRCC1 KMT2E MBD3 ZFPM2 HP1BP3 BPTF ARID1B BRD2 PIAS3 PHF20L1 NFATC2 ATXN7 MORF4L2 ANKRD11 SMARCC1 TAF6 DNMT1 | 2.66e-05 | 1480 | 162 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | microtubule end | 2.09e-04 | 38 | 162 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 3.12e-04 | 276 | 162 | 9 | GO:0000775 | |
| GeneOntologyCellularComponent | kinetochore | 5.37e-04 | 181 | 162 | 7 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 7.84e-04 | 193 | 162 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.10e-04 | 96 | 162 | 5 | GO:0070603 | |
| Domain | SPIN-2 | 7.57e-05 | 2 | 163 | 2 | IPR029564 | |
| Domain | SAM | 1.21e-04 | 88 | 163 | 6 | SM00454 | |
| Domain | DUF4599 | 1.36e-04 | 12 | 163 | 3 | PF15371 | |
| Domain | DUF4599 | 1.36e-04 | 12 | 163 | 3 | IPR027970 | |
| Domain | SAM_DOMAIN | 1.85e-04 | 95 | 163 | 6 | PS50105 | |
| Domain | SAM | 2.07e-04 | 97 | 163 | 6 | IPR001660 | |
| Domain | CAMSAP_CC1 | 2.26e-04 | 3 | 163 | 2 | PF17095 | |
| Domain | CAMSAP_CKK | 2.26e-04 | 3 | 163 | 2 | SM01051 | |
| Domain | PRC_barrel-like | 2.26e-04 | 3 | 163 | 2 | IPR011033 | |
| Domain | CKK_domain | 2.26e-04 | 3 | 163 | 2 | IPR014797 | |
| Domain | CAMSAP_CKK | 2.26e-04 | 3 | 163 | 2 | PF08683 | |
| Domain | CAMSAP_CC1 | 2.26e-04 | 3 | 163 | 2 | IPR031372 | |
| Domain | CAMSAP | 2.26e-04 | 3 | 163 | 2 | IPR032940 | |
| Domain | CKK | 2.26e-04 | 3 | 163 | 2 | PS51508 | |
| Domain | BROMODOMAIN_2 | 4.40e-04 | 41 | 163 | 4 | PS50014 | |
| Domain | Bromodomain | 4.83e-04 | 42 | 163 | 4 | IPR001487 | |
| Domain | BROMO | 4.83e-04 | 42 | 163 | 4 | SM00297 | |
| Domain | - | 4.83e-04 | 42 | 163 | 4 | 1.20.920.10 | |
| Domain | SAM/pointed | 5.67e-04 | 117 | 163 | 6 | IPR013761 | |
| Domain | SPIN/Ssty | 7.44e-04 | 5 | 163 | 2 | IPR003671 | |
| Domain | Spin-Ssty | 7.44e-04 | 5 | 163 | 2 | PF02513 | |
| Pathway | REACTOME_NUCLEOTIDE_EXCISION_REPAIR | 1.77e-05 | 108 | 107 | 7 | M7927 | |
| Pathway | REACTOME_NUCLEOTIDE_EXCISION_REPAIR | 1.77e-05 | 108 | 107 | 7 | MM15304 | |
| Pathway | REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER | 4.18e-05 | 84 | 107 | 6 | M27594 | |
| Pubmed | CBLL1 NUSAP1 NCAPD3 GNL3L ERCC6 MAGED1 BMP2K RBBP6 SYNE1 AHCTF1 SIPA1L3 MINK1 TRPS1 APC YTHDC2 XPC ZNF318 XRCC1 GPATCH8 TTF1 MBD3 TOE1 PHC3 AFAP1 NOP14 DST BRD2 NFATC2 ATXN7 MORF4L2 ANLN RBM19 ARHGEF9 ANKRD11 KMT2A KIF2A TAF6 CAMSAP2 ZNF281 FHIP1A | 5.24e-19 | 1497 | 168 | 40 | 31527615 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PDS5B ATXN2L NCAPD3 TCOF1 EARS2 RBBP6 GPATCH1 TRPS1 WDR46 XRCC1 RBM28 CHAMP1 MBD3 HP1BP3 ITPR2 SART1 BPTF ARID1B NOP14 ZNF638 KMT2A ZNF281 | 1.72e-18 | 341 | 168 | 22 | 32971831 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CBLL1 NPM1 PDS5B ATXN2L EXOSC10 RBBP6 AHCTF1 GPATCH1 ZDBF2 ZNF318 XRCC1 RBM28 RFC1 SSX1 CHAMP1 MBD3 HP1BP3 SART1 BPTF PHC3 ARID1B BRD2 ANLN RBM19 ANKRD11 ZNF638 SMARCC1 KMT2A TAF6 ZNF281 DNMT1 | 4.10e-17 | 954 | 168 | 31 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NUSAP1 PDS5B GNL3L ERCC6 ZNF280D AHCTF1 XPC XRCC1 GPATCH8 RFC1 CHAMP1 MBD3 HP1BP3 BPTF PHC3 NOP14 BRD2 PHF20L1 MORF4L2 ANLN SMARCC1 KMT2A ZNF281 DNMT1 BRWD1 | 2.93e-16 | 608 | 168 | 25 | 36089195 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 NUSAP1 NPM1 NCAPD3 EXOSC10 TCOF1 RBBP6 AHCTF1 GPATCH1 XPC ZNF318 RPL14 XRCC1 RBM28 GPATCH8 RFC1 CHAMP1 TTF1 MBD3 HP1BP3 SART1 BPTF PHC3 RCOR1 DST BRD2 MORF4L2 ANKRD11 ZNF638 SMARCC1 KMT2A TAF6 ZNF281 DNMT1 | 5.81e-16 | 1294 | 168 | 34 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 NPM1 PDS5B EXOSC10 MAP1A TCOF1 RBBP6 SYNE1 SMURF1 APC XPC RPL14 GPATCH8 CHAMP1 MBD3 TOE1 HP1BP3 SART1 BPTF ARID1B AFAP1 NOP14 DST BRD2 MORF4L2 NEMF ZNF638 SMARCC1 KIF2A ZNF281 DYNC1LI2 | 1.31e-15 | 1082 | 168 | 31 | 38697112 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B ATXN2L NCAPD3 TCOF1 RBBP6 MINK1 YTHDC2 XPC ZNF318 IQCN GPATCH8 RFC1 CHAMP1 SART1 BPTF PHC3 BRD2 ATXN7 ANLN ZNF638 SMARCC1 KMT2A TAF6 MN1 DYNC1LI2 DNMT1 | 8.46e-15 | 774 | 168 | 26 | 15302935 |
| Pubmed | NPM1 GNL3L ERCC6 MAP1A TCOF1 EARS2 RBBP6 AHCTF1 TRPS1 YTHDC2 XPC ZNF318 CHAMP1 ZC3H3 MBD3 JPH1 SART1 BPTF RCOR1 ARID1B BRD2 ATXN1 ATXN7 MORF4L2 SMARCC1 USP54 LONRF3 TAF6 ZNF281 BRWD1 | 2.11e-14 | 1116 | 168 | 30 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NPM1 ATXN2L EXOSC10 GNL3L MAP1A TCOF1 RBBP6 AHCTF1 GPATCH1 YTHDC2 ZNF318 RPL14 RFC1 CHAMP1 HP1BP3 USP14 PHC3 DST CEP44 ZNF638 KMT2A TAF6 CAMSAP1 CAMSAP2 ZNF281 KLC1 DNMT1 | 8.92e-14 | 934 | 168 | 27 | 33916271 |
| Pubmed | NPM1 PDS5B ATXN2L EXOSC10 HYOU1 TCOF1 AHCTF1 WDR46 YTHDC2 ZNF318 RPL14 RBM28 RFC1 TTF1 HP1BP3 SART1 BPTF NOP14 DST ZNF638 SMARCC1 KMT2A DNMT1 | 1.28e-13 | 653 | 168 | 23 | 22586326 | |
| Pubmed | CBLL1 PDS5B MAGED1 RBBP6 AHCTF1 RFC1 MBD3 TOE1 ZFPM2 BPTF RCOR1 BRD2 MORF4L2 CEP44 ZNF638 SMARCC1 KMT2A ZNF281 DNMT1 | 1.76e-12 | 469 | 168 | 19 | 27634302 | |
| Pubmed | NPM1 NCAPD3 ERCC6 AHCTF1 WDR46 GPATCH8 RFC1 TTF1 PHC3 RCOR1 NOP14 ZNF638 KMT2A KIF2A | 2.29e-12 | 210 | 168 | 14 | 16565220 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CBLL1 NUSAP1 NPM1 ATXN2L EXOSC10 GNL3L SAMD9 ERCC6 HYOU1 RBBP6 AHCTF1 SIPA1L3 YTHDC2 RPL14 RBM28 RFC1 TOE1 HP1BP3 ITPR2 SART1 TXLNA AFAP1 NOP14 DST ANLN RBM19 ZNF638 KIF2A DNMT1 | 2.65e-12 | 1257 | 168 | 29 | 36526897 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUSAP1 NPM1 PDS5B ATXN2L NCAPD3 EXOSC10 ERCC6 RBBP6 YTHDC2 RPL14 XRCC1 RBM28 RFC1 TTF1 HP1BP3 SART1 BPTF TXLNA NOP14 MORF4L2 NEMF KIF2A DNMT1 | 2.80e-12 | 759 | 168 | 23 | 35915203 |
| Pubmed | NUSAP1 PDS5B ATXN2L NCAPD3 SP4 EXOSC10 HYOU1 ZNF318 XRCC1 RBM28 RFC1 MBD3 SART1 USP14 BPTF TXLNA RCOR1 ARID1B NOP14 ANLN SMARCC1 KMT2A KIF2A TAF6 ZNF281 MNDA DNMT1 | 4.29e-12 | 1103 | 168 | 27 | 34189442 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | EXOSC10 RBBP6 AHCTF1 GPATCH1 YTHDC2 ZNF318 XRCC1 RFC1 CHAMP1 SART1 USP14 BPTF ZNF638 ZNF281 DNMT1 | 9.91e-12 | 283 | 168 | 15 | 30585729 |
| Pubmed | EXOSC10 GNL3L MAGED1 ZDBF2 ZNF318 CHAMP1 MBD3 SART1 RCOR1 ARID1B BRD2 ATXN7 ANLN KMT2A ZNF281 DNMT1 | 1.13e-11 | 339 | 168 | 16 | 30415952 | |
| Pubmed | PDS5B NCAPD3 ERCC6 ZNF318 CHAMP1 NOP14 BRD2 PIAS3 ATXN7 KIF2A ZNF518B POLK ZNF281 | 7.28e-11 | 222 | 168 | 13 | 37071664 | |
| Pubmed | ATXN2L GNL3L MAGED1 HYOU1 APC ZDBF2 XRCC1 RBM28 GPATCH8 MBD3 ITPR2 JPH1 USP14 ARID1B ANLN ZNF638 TMEM131 USP54 CAMSAP1 DYNC1LI2 DNMT1 | 7.49e-11 | 733 | 168 | 21 | 34672954 | |
| Pubmed | NUSAP1 MAGED1 RBBP6 TRPS1 ZNF318 RPL14 XRCC1 RBM28 GPATCH8 RFC1 ZFPM2 HP1BP3 BPTF PHC3 RCOR1 ARID1B NOP14 DST BRD2 ATXN1 ATXN7 MORF4L2 ZNF638 SMARCC1 KMT2A USP54 TAF6 ZNF281 | 2.84e-10 | 1429 | 168 | 28 | 35140242 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | NPM1 ATXN2L EXOSC10 TCOF1 GPATCH1 APC YTHDC2 ZNF318 RBM28 GPATCH8 ITPR2 ARID1B SMARCC1 KIF2A USP54 CAMSAP1 | 5.23e-10 | 440 | 168 | 16 | 34244565 |
| Pubmed | NUSAP1 EXOSC10 HYOU1 BMP2K AHCTF1 SMURF1 APC BBS4 ZNF318 RBM28 GPATCH8 COPS7A PHC3 RCOR1 ARID1B ANLN SBF2 ZNF638 SMARCC1 TMEM131 KIF2A POLK DYNC1LI2 BRWD1 | 5.65e-10 | 1084 | 168 | 24 | 11544199 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L COBLL1 SIPA1L3 MINK1 BRSK2 APC DST DLC1 ATXN1 ANLN DYRK1B ANKRD11 KMT2A KIF2A ARHGEF4 USP54 CAMSAP1 CAMSAP2 CSPP1 KLC1 DNMT1 | 1.36e-09 | 861 | 168 | 21 | 36931259 |
| Pubmed | 1.45e-09 | 24 | 168 | 6 | 32212159 | ||
| Pubmed | 1.96e-09 | 103 | 168 | 9 | 32744500 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NPM1 PDS5B EXOSC10 GNL3L ERCC6 AHCTF1 WDR46 XPC RPL14 RBM28 RFC1 TOE1 SART1 USP14 NOP14 DST ANLN IGHG1 MAP4K5 RBM19 ZNF638 SMARCC1 KIF2A DDX43 ZNF281 DNMT1 | 1.99e-09 | 1353 | 168 | 26 | 29467282 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NUSAP1 NPM1 EXOSC10 GNL3L TCOF1 WDR46 RPL14 RBM28 GPATCH8 RFC1 CHAMP1 TOE1 SART1 BPTF NOP14 BRD2 ANLN RBM19 ZNF638 SMARCC1 KIF2A DNMT1 | 2.89e-09 | 989 | 168 | 22 | 36424410 |
| Pubmed | NCAPD3 GNL3L SAMD9 MAGED1 HYOU1 MINK1 APC YTHDC2 HP1BP3 TXLNA DST NEMF BUB1 ZNF638 SMARCC1 KMT2A KIF2A DNMT1 | 3.14e-09 | 650 | 168 | 18 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBR2 CACNB3 GNL3L SIPA1L3 MINK1 TRPS1 SMURF1 SAMD12 IQCN TTF1 HP1BP3 USP14 BPTF LATS2 ZNF544 ATXN1 ATXN7 SBF2 NEMF TBC1D14 ARHGEF9 ANKRD11 ZNF638 LUZP2 ASPSCR1 ARHGEF4 POLK | 3.25e-09 | 1489 | 168 | 27 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 SP4 MAGED1 AFF2 MAP1A TCOF1 RBBP6 KMT2E PHC3 PIAS3 MAP4K5 BUB1 CAMSAP1 FHIP1A KLC1 | 3.26e-09 | 430 | 168 | 15 | 35044719 |
| Pubmed | NPM1 RBBP6 XPC CHAMP1 TOE1 HP1BP3 SART1 BPTF BRD2 ZNF638 SMARCC1 KMT2A | 4.01e-09 | 251 | 168 | 12 | 31076518 | |
| Pubmed | NPM1 ATXN2L EXOSC10 TCOF1 AHCTF1 RPL14 XRCC1 RFC1 HP1BP3 SART1 NOP14 BRD2 MORF4L2 KIF2A DNMT1 | 4.58e-09 | 441 | 168 | 15 | 31239290 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NUSAP1 NPM1 ATXN2L GNL3L BMP2K TCOF1 RBBP6 SYNE1 AHCTF1 WDR46 RPL14 XRCC1 RBM28 TOE1 HP1BP3 JPH1 SART1 DST IGHG1 KIF2A TAF6 | 7.47e-09 | 949 | 168 | 21 | 36574265 |
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 7.82e-09 | 6 | 168 | 4 | 25930072 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NPM1 TRPS1 APC XRCC1 ZFPM2 PHC3 ARID1B BRD2 ANLN DYRK1B SMARCC1 ZNF518B USP54 DNMT1 | 1.00e-08 | 398 | 168 | 14 | 35016035 |
| Pubmed | NUSAP1 NPM1 ATXN2L EXOSC10 GNL3L TCOF1 AHCTF1 COBLL1 SIPA1L3 XPC RPL14 RBM28 RFC1 TTF1 MBD3 TOE1 HP1BP3 PHC3 TXLNA TCHHL1 RBM19 NEMF SMARCC1 KMT2A DNMT1 | 1.19e-08 | 1371 | 168 | 25 | 36244648 | |
| Pubmed | ATXN2L EXOSC10 TCOF1 RBBP6 AHCTF1 ZNF318 CHAMP1 USP14 BPTF ARID1B ANLN SMARCC1 KMT2A TAF6 KLC1 DNMT1 | 1.21e-08 | 549 | 168 | 16 | 38280479 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L MAGED1 HYOU1 MAP1A BMP2K MINK1 WDR46 APC YTHDC2 XPC MBD3 SART1 TXLNA RBM19 SMARCC1 TMEM131 CAMSAP1 ZNF281 | 1.65e-08 | 724 | 168 | 18 | 36232890 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CBLL1 NPM1 PDS5B ATXN2L NCAPD3 MAGED1 BMP2K TCOF1 RBBP6 AHCTF1 XPC RPL14 GPATCH8 KMT2E CHAMP1 HP1BP3 SART1 ARID1B NOP14 PIAS3 MORF4L2 SMARCC1 ZNF281 | 2.06e-08 | 1203 | 168 | 23 | 29180619 |
| Pubmed | ATXN2L ERCC6 TCOF1 RBBP6 AHCTF1 COBLL1 APC RFC1 CHAMP1 ANLN ZNF638 TMEM131 TAF6 KLC1 DYNC1LI2 | 2.62e-08 | 503 | 168 | 15 | 16964243 | |
| Pubmed | NPM1 ATXN2L HYOU1 MAP1A SYNE1 SIPA1L3 MINK1 BRSK2 SMURF1 APC YTHDC2 RPL14 HP1BP3 ITPR2 AFAP1 DST MORF4L2 IGHG1 SLC4A10 KMT2A KIF2A ARHGEF4 USP54 CAMSAP2 KLC1 | 2.75e-08 | 1431 | 168 | 25 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NPM1 PDS5B EXOSC10 HYOU1 TCOF1 SYNE1 WDR46 YTHDC2 ZNF318 RPL14 XRCC1 RBM28 HP1BP3 ITPR2 SART1 BPTF DST BRD2 IGHG1 ZNF638 KIF2A | 2.76e-08 | 1024 | 168 | 21 | 24711643 |
| Pubmed | NPM1 PDS5B HYOU1 SYNE1 SIPA1L3 XPC ZNF318 RPL14 HP1BP3 ADAMTS12 SART1 BPTF NOP14 DST LATS2 BRD2 PHF20L1 ATXN7 TCHHL1 SMARCC1 KMT2A ARHGEF4 ATP1A4 CAMSAP2 MNDA | 3.19e-08 | 1442 | 168 | 25 | 35575683 | |
| Pubmed | NPM1 ATXN2L NCAPD3 EXOSC10 GNL3L ERCC6 TCOF1 RBBP6 AHCTF1 XPC RPL14 RBM28 RFC1 TOE1 HP1BP3 SART1 NOP14 ZNF638 KMT2A | 3.30e-08 | 847 | 168 | 19 | 35850772 | |
| Pubmed | 4.25e-08 | 195 | 168 | 10 | 19454010 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NPM1 EXOSC10 GNL3L TCOF1 RPL14 RBM28 RFC1 MBD3 HP1BP3 SART1 NOP14 BRD2 RBM19 ZNF638 SMARCC1 KMT2A | 4.65e-08 | 605 | 168 | 16 | 28977666 |
| Pubmed | NPM1 EXOSC10 AFF2 BMP2K TCOF1 GPATCH1 MINK1 APC GPRIN3 ZNF318 HP1BP3 SART1 DST RBM19 ZNF638 CAMSAP1 DYNC1LI2 DNMT1 | 4.80e-08 | 777 | 168 | 18 | 35844135 | |
| Pubmed | CBLL1 NPM1 MAGED1 TCOF1 SYNE1 SIPA1L3 MINK1 APC ZNF318 MBD3 SART1 TXLNA RCOR1 DST SMARCC1 KIF2A CAMSAP1 CAMSAP2 KLC1 DNMT1 | 4.94e-08 | 963 | 168 | 20 | 28671696 | |
| Pubmed | NPM1 ATXN2L EXOSC10 TCOF1 YTHDC2 RPL14 RBM28 RFC1 TOE1 HP1BP3 SART1 ARID1B NEMF ZNF638 SMARCC1 KIF2A | 5.82e-08 | 615 | 168 | 16 | 31048545 | |
| Pubmed | MAGED1 HYOU1 AHCTF1 APC YTHDC2 ZNF318 LATS2 ZNF638 TMEM131 USP54 CAMSAP1 | 7.11e-08 | 263 | 168 | 11 | 34702444 | |
| Pubmed | PDS5B SP4 ZNF280D AHCTF1 TRPS1 ZNF318 TOE1 SART1 BPTF BRD2 PIAS3 PHF20L1 ATXN1 ZNF638 SMARCC1 TAF6 PLXNA1 DNMT1 | 8.60e-08 | 808 | 168 | 18 | 20412781 | |
| Pubmed | EXOSC10 TRPS1 CHAMP1 SART1 RCOR1 ARID1B ATXN1 ANLN SMARCC1 KMT2A ZNF281 | 8.60e-08 | 268 | 168 | 11 | 33640491 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | NPM1 EXOSC10 TCOF1 AHCTF1 ZNF318 RFC1 BPTF ANLN ZNF638 SMARCC1 ATP1A4 | 9.63e-08 | 271 | 168 | 11 | 32433965 |
| Pubmed | NUSAP1 GNL3L XPC XRCC1 RFC1 TXLNA RCOR1 DST BRD2 MORF4L2 ANLN DYRK1B ZNF638 KMT2A CAMSAP1 CSPP1 | 1.11e-07 | 645 | 168 | 16 | 25281560 | |
| Pubmed | NUSAP1 PDS5B EXOSC10 RBBP6 TRPS1 XRCC1 GPATCH8 RFC1 CHAMP1 MBD3 HP1BP3 SART1 USP14 BPTF RCOR1 BRD2 SMARCC1 KMT2A TAF6 DNMT1 | 1.13e-07 | 1014 | 168 | 20 | 32416067 | |
| Pubmed | MAP1A RBBP6 SYNE1 COBLL1 APC NCKAP5 DST KIAA1549L PIAS3 ATXN1 MAP4K5 DYRK1B ARHGEF9 ARHGEF4 | 1.19e-07 | 486 | 168 | 14 | 20936779 | |
| Pubmed | ZNF280D TRPS1 APC ZDBF2 ZNF318 CHAMP1 PHC3 RCOR1 DST CEP44 BUB1 CAMSAP1 KLC1 | 1.43e-07 | 418 | 168 | 13 | 34709266 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B GNL3L ERCC6 YTHDC2 TOE1 HP1BP3 COPS7A SART1 PI3 ANKRD11 KMT2A KIF2A GALNT5 CSPP1 | 1.56e-07 | 497 | 168 | 14 | 36774506 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NUSAP1 PDS5B SYNE1 AHCTF1 SIPA1L3 TRPS1 APC XPC CHAMP1 COPS7A JPH1 SART1 PTTG3P RCOR1 ARID1B PHF20L1 ANLN BUB1 SMARCC1 DYNC1LI2 PTTG2 | 2.06e-07 | 1155 | 168 | 21 | 20360068 |
| Pubmed | 2.11e-07 | 86 | 168 | 7 | 37253089 | ||
| Pubmed | EXOSC10 SYNE1 COBLL1 MINK1 RFC1 DST KIAA1549L IGHG1 SMARCC1 CAMSAP1 | 2.33e-07 | 234 | 168 | 10 | 36243803 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.89e-07 | 90 | 168 | 7 | 35654790 | |
| Pubmed | MAGED1 GPATCH1 APC YTHDC2 SLC35B2 ZNF318 TXLNA BUB1 CAMSAP1 ZNF281 | 3.18e-07 | 242 | 168 | 10 | 34011540 | |
| Pubmed | CBLL1 NPM1 HYOU1 MAP1A WDR46 APC XRCC1 TTF1 TGOLN2 ITPR2 PHC3 DST DLC1 BRD2 ZNF35 ATXN1 ATXN7 BUB1 ARHGEF9 ZNF638 ZNF281 KLC1 | 3.19e-07 | 1293 | 168 | 22 | 15342556 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | PDS5B XRCC1 RFC1 MBD3 HP1BP3 BPTF PHC3 BRD2 SMARCC1 KMT2A KIF2A TAF6 ZNF281 DNMT1 | 3.62e-07 | 533 | 168 | 14 | 30554943 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NPM1 PDS5B NCAPD3 GNL3L HYOU1 ZNF280D TCOF1 SYNE1 WDR46 YTHDC2 RPL14 RFC1 MBD3 TOE1 SART1 TXLNA RBM19 NEMF SMARCC1 KIF2A GALNT5 PLXNA1 DNMT1 | 4.21e-07 | 1425 | 168 | 23 | 30948266 |
| Pubmed | UBR2 HYOU1 BMP2K TCOF1 SIPA1L3 XPC RPL14 RBM28 GPATCH8 HP1BP3 COPS7A ARID1B DST IGHG1 SMARCC1 | 5.12e-07 | 634 | 168 | 15 | 34591612 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NPM1 NCAPD3 EXOSC10 GPATCH8 CHAMP1 SART1 BPTF ANLN ZNF638 KIF2A DNMT1 | 7.25e-07 | 332 | 168 | 11 | 32786267 |
| Pubmed | EXOSC10 SYNE1 AHCTF1 WDR46 YTHDC2 RBM28 HP1BP3 SART1 RBM19 NEMF ZNF638 | 7.25e-07 | 332 | 168 | 11 | 25693804 | |
| Pubmed | NUSAP1 NPM1 EXOSC10 WDR46 YTHDC2 RPL14 RBM28 RFC1 HP1BP3 NOP14 RBM19 SPIN2A ZNF638 | 7.33e-07 | 483 | 168 | 13 | 36912080 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 7.37e-07 | 150 | 168 | 8 | 28242625 | |
| Pubmed | NPM1 ATXN2L MAGED1 TCOF1 RBBP6 TRPS1 RPL14 RBM28 RFC1 MBD3 HP1BP3 SART1 RCOR1 USP54 TAF6 | 7.69e-07 | 655 | 168 | 15 | 35819319 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | NUSAP1 GNL3L AHCTF1 MBD3 ZFPM2 BPTF RCOR1 BRD2 ZNF638 SMARCC1 KMT2A ZNF281 | 8.52e-07 | 411 | 168 | 12 | 35182466 |
| Pubmed | NPM1 EXOSC10 MAGED1 HYOU1 TCOF1 EARS2 SYNE1 AHCTF1 MINK1 RPL14 RBM28 HP1BP3 ITPR2 JPH1 TXLNA NOP14 BRD2 MAP4K5 ANKRD11 TMEM131 CSPP1 KLC1 DNMT1 | 8.76e-07 | 1487 | 168 | 23 | 33957083 | |
| Pubmed | 8.91e-07 | 209 | 168 | 9 | 36779422 | ||
| Pubmed | EXOSC10 MAP1A RBBP6 MAGIX TRPS1 RFC1 MBD3 ATRIP RBM19 NEMF SPIN2A KIF2A LONRF3 | 9.85e-07 | 496 | 168 | 13 | 31343991 | |
| Pubmed | 1.04e-06 | 157 | 168 | 8 | 30186101 | ||
| Pubmed | 1.10e-06 | 5 | 168 | 3 | 28658604 | ||
| Pubmed | DOCK3 ADAM19 MAGED1 TCOF1 SYNE1 SIPA1L3 TRPS1 APC NCKAP5 XPC JPH1 DST BRD2 PIAS3 MORF4L2 NEMF TMEM131 USP54 TAF6 DNMT1 BRWD1 | 1.15e-06 | 1285 | 168 | 21 | 35914814 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | ATXN2L EXOSC10 WDR46 YTHDC2 XRCC1 RBM28 HP1BP3 NOP14 RBM19 MNDA DNMT1 | 1.18e-06 | 349 | 168 | 11 | 25665578 |
| Pubmed | NPM1 TCOF1 RBBP6 AHCTF1 COBLL1 ZNF318 RPL14 MBD3 SART1 DST ANLN SMARCC1 TAF6 | 1.23e-06 | 506 | 168 | 13 | 30890647 | |
| Pubmed | NUSAP1 NPM1 ATXN2L NCAPD3 MAGED1 TCOF1 YTHDC2 RPL14 RBM28 RFC1 SART1 TXLNA NOP14 DLC1 MORF4L2 BUB1 SMARCC1 DNMT1 | 1.23e-06 | 971 | 168 | 18 | 33306668 | |
| Pubmed | 1.62e-06 | 116 | 168 | 7 | 21282530 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | CBLL1 AHCTF1 APC ZNF318 RPL14 RBM28 HP1BP3 ANLN ZNF638 TMEM131 CAMSAP2 | 1.64e-06 | 361 | 168 | 11 | 30344098 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NPM1 PDS5B HYOU1 BMP2K TCOF1 RBBP6 AHCTF1 WDR46 RPL14 RBM28 RFC1 TTF1 TOE1 HP1BP3 NOP14 SMARCC1 KMT2A KIF2A DDX43 TAF6 DNMT1 | 1.72e-06 | 1318 | 168 | 21 | 30463901 |
| Pubmed | 1.78e-06 | 75 | 168 | 6 | 25593309 | ||
| Pubmed | NPM1 EXOSC10 RBBP6 YTHDC2 RPL14 RBM28 GPATCH8 RFC1 TOE1 HP1BP3 SART1 NOP14 IGHG1 ZNF638 KIF2A | 2.19e-06 | 713 | 168 | 15 | 29802200 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | BMP2K MINK1 BRSK2 GPATCH8 ANKRD36C MBD3 ITPR2 TXLNA DST LATS2 BRD2 ANLN MAP4K5 BUB1 KMT2A DDX43 KLC1 | 2.24e-06 | 910 | 168 | 17 | 36736316 |
| Pubmed | 2.54e-06 | 124 | 168 | 7 | 20850016 | ||
| Pubmed | HYOU1 RBBP6 YTHDC2 RBM28 CHAMP1 TOE1 HP1BP3 COPS7A SART1 DST NEMF KIF2A CAMSAP1 | 2.89e-06 | 547 | 168 | 13 | 37267103 | |
| Pubmed | 2.95e-06 | 21 | 168 | 4 | 12453419 | ||
| Pubmed | 3.22e-06 | 83 | 168 | 6 | 28794006 | ||
| Pubmed | 3.27e-06 | 183 | 168 | 8 | 36129980 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.41e-06 | 184 | 168 | 8 | 32908313 | |
| Pubmed | SAMD9 MAP1A CHAMP1 COPS7A BPTF ARID1B AFAP1 DST ANLN ASPSCR1 CAMSAP1 DYNC1LI2 | 3.55e-06 | 472 | 168 | 12 | 38943005 | |
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 23540691 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | NPM1 NCAPD3 EXOSC10 GNL3L YTHDC2 RPL14 GPATCH8 RFC1 NEMF SMARCC1 KIF2A DNMT1 | 4.78e-06 | 486 | 168 | 12 | 30940648 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | GNL3L TCOF1 WDR46 XPC CHAMP1 TTF1 RCOR1 DST ATRIP IGHG1 TAF6 | 5.52e-06 | 410 | 168 | 11 | 26949251 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 5.64e-06 | 197 | 168 | 8 | 20811636 | |
| Interaction | NUP43 interactions | NPM1 PDS5B GNL3L ZNF280D RBBP6 AHCTF1 GPATCH1 APC ZDBF2 XPC ZNF318 RBM28 GPATCH8 RFC1 CHAMP1 TTF1 HP1BP3 BPTF PHC3 ARID1B NOP14 DST PHF20L1 RBM19 ANKRD11 SMARCC1 KMT2A KIF2A TAF6 ZNF281 | 3.56e-15 | 625 | 164 | 30 | int:NUP43 |
| Interaction | MEN1 interactions | NPM1 PDS5B ATXN2L NCAPD3 EXOSC10 GNL3L ERCC6 TCOF1 EARS2 RBBP6 AHCTF1 GPATCH1 TRPS1 WDR46 XPC RPL14 XRCC1 RBM28 RFC1 CHAMP1 MBD3 TOE1 HP1BP3 ITPR2 SART1 BPTF ARID1B NOP14 PHF20L1 ANLN ZNF638 KMT2A ZNF281 | 1.00e-11 | 1029 | 164 | 33 | int:MEN1 |
| Interaction | MECP2 interactions | CBLL1 NUSAP1 NPM1 PDS5B ATXN2L EXOSC10 MAP1A TCOF1 RBBP6 SYNE1 SMURF1 APC XPC RPL14 RBM28 GPATCH8 CHAMP1 MBD3 TOE1 HP1BP3 SART1 BPTF RCOR1 ARID1B AFAP1 NOP14 DST BRD2 MORF4L2 ANLN NEMF ZNF638 SMARCC1 KIF2A ZNF281 DYNC1LI2 DNMT1 | 1.09e-11 | 1287 | 164 | 37 | int:MECP2 |
| Interaction | H2BC8 interactions | NUSAP1 NPM1 PDS5B UBR2 EXOSC10 GNL3L ZNF280D AHCTF1 XPC XRCC1 RFC1 CHAMP1 HP1BP3 BPTF PHC3 RCOR1 NOP14 BRD2 MORF4L2 ANLN SMARCC1 KMT2A ZNF281 DNMT1 | 5.17e-11 | 576 | 164 | 24 | int:H2BC8 |
| Interaction | SNRNP40 interactions | CBLL1 NPM1 ZNF280D TCOF1 RBBP6 AHCTF1 GPATCH1 ZDBF2 XPC ZNF318 XRCC1 RBM28 GPATCH8 RFC1 TOE1 SART1 USP14 PHC3 ARID1B NOP14 PHF20L1 ANLN SMARCC1 KMT2A ZNF281 | 7.02e-11 | 637 | 164 | 25 | int:SNRNP40 |
| Interaction | SMC5 interactions | CBLL1 NPM1 PDS5B ATXN2L EXOSC10 RBBP6 AHCTF1 GPATCH1 ZDBF2 ZNF318 XRCC1 RBM28 RFC1 SSX1 CHAMP1 MBD3 HP1BP3 SART1 BPTF PHC3 ARID1B BRD2 ANLN RBM19 ANKRD11 ZNF638 SMARCC1 KMT2A TAF6 ZNF281 DNMT1 | 1.10e-10 | 1000 | 164 | 31 | int:SMC5 |
| Interaction | ZNF330 interactions | NUSAP1 NPM1 PDS5B EXOSC10 GNL3L XPC XRCC1 RBM28 GPATCH8 RFC1 HP1BP3 NOP14 BRD2 ANLN RBM19 ANKRD11 SMARCC1 KMT2A ZNF281 DNMT1 | 6.76e-10 | 446 | 164 | 20 | int:ZNF330 |
| Interaction | H3C1 interactions | NUSAP1 NPM1 PDS5B EXOSC10 ERCC6 ZNF280D SYNE1 AHCTF1 COBLL1 WDR46 XPC XRCC1 RBM28 RFC1 CHAMP1 MBD3 HP1BP3 BPTF RCOR1 BRD2 ATXN1 ANLN ZNF638 KMT2A TAF6 CAMSAP1 ZNF281 DNMT1 | 9.53e-10 | 901 | 164 | 28 | int:H3C1 |
| Interaction | UHRF2 interactions | NPM1 NCAPD3 XRCC1 CHAMP1 MBD3 SART1 BPTF RCOR1 ATXN1 ANLN ZNF638 KMT2A DNMT1 BRWD1 | 1.02e-09 | 200 | 164 | 14 | int:UHRF2 |
| Interaction | HDAC1 interactions | NPM1 ERCC6 TRPS1 APC ZDBF2 ZNF318 RFC1 KMT2E MBD3 ZFPM2 BPTF RCOR1 DST LATS2 PIAS3 PHF20L1 NFATC2 ATXN1 MORF4L2 ANLN CEP44 BUB1 ZNF638 SMARCC1 KMT2A KIF2A TAF6 CAMSAP1 PHF21B KLC1 DNMT1 | 1.35e-09 | 1108 | 164 | 31 | int:HDAC1 |
| Interaction | H3-3A interactions | NUSAP1 PDS5B ERCC6 ZNF280D AHCTF1 SMURF1 XPC XRCC1 GPATCH8 RFC1 CHAMP1 MBD3 HP1BP3 BPTF NOP14 BRD2 PHF20L1 MORF4L2 ANLN SMARCC1 KMT2A POLK ZNF281 DNMT1 BRWD1 | 2.02e-09 | 749 | 164 | 25 | int:H3-3A |
| Interaction | H2BC21 interactions | NPM1 PDS5B ZNF280D MAGIX AHCTF1 SMURF1 XPC XRCC1 RFC1 CHAMP1 TTF1 MBD3 HP1BP3 BPTF RCOR1 ARID1B LATS2 KIAA1549L BRD2 MORF4L2 ZNF638 SMARCC1 KMT2A ZNF518B | 2.33e-09 | 696 | 164 | 24 | int:H2BC21 |
| Interaction | CHD4 interactions | NPM1 EXOSC10 GNL3L ERCC6 TCOF1 RBBP6 TRPS1 RPL14 RBM28 GPATCH8 RFC1 CHAMP1 MBD3 HP1BP3 SART1 BPTF RCOR1 NOP14 BRD2 PHF20L1 NFATC2 ATXN1 RBM19 ZNF638 SMARCC1 KMT2A TAF6 DNMT1 | 2.33e-09 | 938 | 164 | 28 | int:CHD4 |
| Interaction | NIFK interactions | NPM1 EXOSC10 GNL3L TCOF1 RBBP6 SMURF1 YTHDC2 RPL14 RBM28 RFC1 TTF1 ZC3H3 TOE1 NOP14 BRD2 ANLN RBM19 ANKRD11 MNDA | 2.47e-09 | 431 | 164 | 19 | int:NIFK |
| Interaction | H3C3 interactions | NUSAP1 PDS5B GNL3L ZNF280D AHCTF1 XPC RFC1 CHAMP1 MBD3 HP1BP3 BPTF PHC3 NOP14 BRD2 MORF4L2 ANLN SMARCC1 KMT2A ZNF281 DNMT1 | 4.04e-09 | 495 | 164 | 20 | int:H3C3 |
| Interaction | NAA40 interactions | NPM1 ATXN2L EXOSC10 GNL3L MAP1A TCOF1 RBBP6 AHCTF1 GPATCH1 YTHDC2 XPC ZNF318 RPL14 RFC1 CHAMP1 HP1BP3 USP14 PHC3 DST CEP44 ZNF638 KMT2A TAF6 CAMSAP1 CAMSAP2 ZNF281 KLC1 DNMT1 | 5.81e-09 | 978 | 164 | 28 | int:NAA40 |
| Interaction | SIRT7 interactions | NPM1 PDS5B ATXN2L EXOSC10 MAGED1 HYOU1 TCOF1 AHCTF1 WDR46 YTHDC2 ZNF318 RPL14 RBM28 RFC1 TTF1 HP1BP3 SART1 BPTF NOP14 DST ZNF638 SMARCC1 KMT2A DNMT1 | 8.51e-09 | 744 | 164 | 24 | int:SIRT7 |
| Interaction | CBX3 interactions | NPM1 PDS5B ZNF280D TCOF1 RBBP6 AHCTF1 COBLL1 XPC XRCC1 RFC1 CHAMP1 HP1BP3 TGOLN2 USP14 NOP14 BRD2 NFATC2 ANLN KMT2A ZNF518B ZNF281 DNMT1 | 1.44e-08 | 646 | 164 | 22 | int:CBX3 |
| Interaction | BRD3 interactions | NPM1 PDS5B RBBP6 XRCC1 RFC1 CHAMP1 MBD3 HP1BP3 JPH1 SART1 BPTF BRD2 ATXN1 SMARCC1 KMT2A KIF2A TAF6 ZNF281 DNMT1 | 2.24e-08 | 494 | 164 | 19 | int:BRD3 |
| Interaction | TERF2IP interactions | PDS5B RBBP6 AHCTF1 ZNF318 XRCC1 RFC1 CHAMP1 HP1BP3 SART1 BPTF PHC3 RCOR1 ANLN ANKRD11 ZNF638 SMARCC1 KMT2A TAF6 ZNF281 DNMT1 | 2.51e-08 | 552 | 164 | 20 | int:TERF2IP |
| Interaction | HECTD1 interactions | NUSAP1 NPM1 PDS5B ATXN2L NCAPD3 EXOSC10 ERCC6 RBBP6 GPATCH1 APC YTHDC2 RPL14 XRCC1 RBM28 RFC1 TTF1 HP1BP3 TGOLN2 SART1 BPTF TXLNA NOP14 MORF4L2 NEMF ANKRD11 KIF2A DNMT1 | 2.73e-08 | 984 | 164 | 27 | int:HECTD1 |
| Interaction | APEX1 interactions | NPM1 PDS5B GNL3L BMP2K TCOF1 AHCTF1 TRPS1 UBXN6 WDR46 RPL14 IQCN XRCC1 RFC1 CHAMP1 HP1BP3 TGOLN2 BPTF RASGRP1 NOP14 BRD2 ANLN ANKRD11 ZNF638 SMARCC1 KMT2A LONRF3 POLK ZNF281 KLC1 DNMT1 BRWD1 | 3.34e-08 | 1271 | 164 | 31 | int:APEX1 |
| Interaction | SLX4 interactions | NPM1 PDS5B NCAPD3 EXOSC10 ERCC6 GPATCH1 ZNF318 RPL14 CHAMP1 SART1 NOP14 BRD2 PIAS3 ATXN7 IGHG1 SMARCC1 KIF2A ZNF518B POLK ZNF281 | 4.50e-08 | 572 | 164 | 20 | int:SLX4 |
| Interaction | POLR1G interactions | NPM1 PDS5B EXOSC10 GNL3L TCOF1 XPC XRCC1 RBM28 RFC1 TTF1 BPTF PHC3 NOP14 BRD2 RBM19 ANKRD11 KMT2A ZNF281 | 1.04e-07 | 489 | 164 | 18 | int:POLR1G |
| Interaction | SSRP1 interactions | NPM1 EXOSC10 RBBP6 SMURF1 XPC RPL14 XRCC1 RFC1 MBD3 SART1 USP14 BRD2 NFATC2 ANLN ANKRD11 ZNF638 SMARCC1 KMT2A SPIN2B TXNDC2 BRWD1 | 1.86e-07 | 685 | 164 | 21 | int:SSRP1 |
| Interaction | FTSJ3 interactions | NPM1 GNL3L MAP1A WDR46 SMURF1 APC RPL14 ZC3H3 HP1BP3 TGOLN2 SART1 NOP14 ATXN1 ANLN RBM19 MNDA | 3.74e-07 | 422 | 164 | 16 | int:FTSJ3 |
| Interaction | H2AX interactions | NPM1 HYOU1 XPC RPL14 XRCC1 GPATCH8 MBD3 SART1 USP14 BPTF RCOR1 ARID1B BRD2 PHF20L1 ATXN1 ANLN RBM19 SMARCC1 MNDA | 3.84e-07 | 593 | 164 | 19 | int:H2AX |
| Interaction | H1-4 interactions | NPM1 TCOF1 YTHDC2 RPL14 RBM28 GPATCH8 RFC1 TTF1 TOE1 HP1BP3 USP14 TXLNA NOP14 BRD2 ATXN7 ANLN RBM19 ZNF638 KMT2A MNDA | 4.06e-07 | 656 | 164 | 20 | int:H1-4 |
| Interaction | CENPA interactions | NPM1 PDS5B ERCC6 XPC RFC1 HP1BP3 BPTF NOP14 BRD2 TBC1D14 ANKRD11 SMARCC1 KMT2A DNMT1 BRWD1 | 4.81e-07 | 377 | 164 | 15 | int:CENPA |
| Interaction | ADARB1 interactions | NPM1 EXOSC10 TCOF1 AHCTF1 WDR46 YTHDC2 RPL14 RBM28 RFC1 TTF1 HP1BP3 BPTF ANLN RBM19 ZNF638 SMARCC1 ATP1A4 | 5.34e-07 | 489 | 164 | 17 | int:ADARB1 |
| Interaction | CIT interactions | NPM1 PDS5B ATXN2L EXOSC10 TCOF1 RBBP6 SYNE1 AHCTF1 YTHDC2 DELE1 RPL14 XRCC1 RBM28 CHAMP1 TOE1 HP1BP3 SART1 BPTF NOP14 LATS2 MORF4L2 ANLN RBM19 SLC4A10 ZNF638 SMARCC1 KMT2A KIF2A TAF6 ZNF281 CSPP1 | 6.18e-07 | 1450 | 164 | 31 | int:CIT |
| Interaction | CSNK2B interactions | NUSAP1 NPM1 ERCC6 TCOF1 MINK1 APC XPC XRCC1 RFC1 MBD3 COPS7A AFAP1 NOP14 BRD2 ATXN1 ANKRD11 KMT2A PTTG2 DNMT1 | 8.46e-07 | 625 | 164 | 19 | int:CSNK2B |
| Interaction | CEBPA interactions | NUSAP1 PDS5B ATXN2L NCAPD3 SP4 EXOSC10 HYOU1 ZNF318 XRCC1 RBM28 RFC1 MBD3 HP1BP3 SART1 USP14 BPTF TXLNA RCOR1 ARID1B NOP14 ANLN SMARCC1 KMT2A KIF2A TAF6 ZNF281 MNDA DNMT1 | 8.81e-07 | 1245 | 164 | 28 | int:CEBPA |
| Interaction | SIRT6 interactions | NPM1 ATXN2L EXOSC10 TCOF1 GPATCH1 APC YTHDC2 ZDBF2 XPC ZNF318 RBM28 GPATCH8 ITPR2 TXLNA ARID1B SMARCC1 KIF2A USP54 CAMSAP1 | 9.08e-07 | 628 | 164 | 19 | int:SIRT6 |
| Interaction | MBD3 interactions | ERCC6 TRPS1 MBD3 BPTF RCOR1 BRD2 PHF20L1 NFATC2 SMARCC1 KMT2A ARHGEF4 TAF6 DNMT1 | 9.26e-07 | 295 | 164 | 13 | int:MBD3 |
| Interaction | IFI16 interactions | EXOSC10 SAMD9 SYNE1 AHCTF1 SIPA1L3 WDR46 YTHDC2 RBM28 RFC1 HP1BP3 SART1 NOP14 NFATC2 MORF4L2 ANLN RBM19 NEMF ZNF638 SMARCC1 DNMT1 | 1.51e-06 | 714 | 164 | 20 | int:IFI16 |
| Interaction | SUMO2 interactions | NPM1 NCAPD3 EXOSC10 ERCC6 GPATCH8 CHAMP1 HP1BP3 SART1 BPTF RCOR1 DST PIAS3 ATXN1 ATXN7 ANLN ZNF638 KIF2A DNMT1 | 1.63e-06 | 591 | 164 | 18 | int:SUMO2 |
| Interaction | CSNK2A2 interactions | NPM1 ERCC6 TCOF1 MINK1 WDR46 SMURF1 XPC XRCC1 ANKRD36C MBD3 PHC3 RCOR1 BRD2 ATXN1 ANLN IGHG1 KMT2A CAMSAP2 ZNF281 DYNC1LI2 | 1.65e-06 | 718 | 164 | 20 | int:CSNK2A2 |
| Interaction | MYCN interactions | CBLL1 NUSAP1 NPM1 PDS5B ATXN2L NCAPD3 GNL3L TCOF1 RBBP6 SYNE1 GPATCH1 YTHDC2 DELE1 RPL14 RBM28 GPATCH8 CHAMP1 TOE1 HP1BP3 SART1 ARID1B NOP14 MORF4L2 IGHG1 RBM19 ZNF638 SMARCC1 KMT2A DNMT1 | 1.93e-06 | 1373 | 164 | 29 | int:MYCN |
| Interaction | RBM19 interactions | NPM1 YTHDC2 RBM28 TTF1 ZC3H3 TOE1 HP1BP3 NOP14 ANLN RBM19 MNDA | 2.03e-06 | 221 | 164 | 11 | int:RBM19 |
| Interaction | LLPH interactions | 2.09e-06 | 139 | 164 | 9 | int:LLPH | |
| Interaction | USP7 interactions | DOCK3 SP4 EXOSC10 ERCC6 MAGED1 SYNE1 COBLL1 MINK1 TRPS1 APC ZDBF2 XPC RFC1 KMT2E USP14 DST DLC1 KIAA1549L ATXN1 ANLN IGHG1 ZNF638 SMARCC1 KIF2A LONRF3 CAMSAP1 KLC1 DNMT1 | 2.49e-06 | 1313 | 164 | 28 | int:USP7 |
| Interaction | MTA2 interactions | ERCC6 TRPS1 MBD3 ZFPM2 TGOLN2 BPTF RCOR1 LATS2 PHF20L1 NFATC2 ATXN1 ANLN SMARCC1 TAF6 DNMT1 | 2.85e-06 | 435 | 164 | 15 | int:MTA2 |
| Interaction | MAPRE3 interactions | MAP1A SIPA1L3 MINK1 APC NCKAP5 DST CEP44 TMEM131 KIF2A CAMSAP1 CAMSAP2 | 2.99e-06 | 230 | 164 | 11 | int:MAPRE3 |
| Interaction | HP1BP3 interactions | NUSAP1 NPM1 WDR46 SMURF1 RPL14 HP1BP3 TGOLN2 USP14 BRD2 ATXN1 ANLN RBM19 MNDA | 3.10e-06 | 329 | 164 | 13 | int:HP1BP3 |
| Interaction | GNL2 interactions | NPM1 MAP1A WDR46 SMURF1 RPL14 RBM28 RFC1 ZC3H3 USP14 NOP14 ANLN RBM19 NEMF MNDA | 3.47e-06 | 386 | 164 | 14 | int:GNL2 |
| Interaction | SOX2 interactions | NUSAP1 NPM1 ATXN2L EXOSC10 MAGED1 MAP1A SIPA1L3 TRPS1 WDR46 YTHDC2 ZDBF2 XRCC1 RBM28 RFC1 CHAMP1 MBD3 ITPR2 COPS7A BPTF PHC3 RCOR1 ARID1B PHF20L1 ATXN1 ZNF638 SMARCC1 KMT2A KIF2A ZNF281 | 3.86e-06 | 1422 | 164 | 29 | int:SOX2 |
| Interaction | NOP56 interactions | NPM1 GNL3L ERCC6 HYOU1 TCOF1 RPL14 RBM28 RFC1 TTF1 NOP14 BRD2 ATXN1 ANLN RBM19 NEMF ANKRD11 MNDA | 4.28e-06 | 570 | 164 | 17 | int:NOP56 |
| Interaction | RBBP4 interactions | NPM1 ERCC6 TRPS1 KMT2E CHAMP1 MBD3 ZFPM2 TGOLN2 BPTF RCOR1 NFATC2 ATXN1 ANLN SMARCC1 KMT2A TAF6 DNMT1 | 4.58e-06 | 573 | 164 | 17 | int:RBBP4 |
| Interaction | RRP15 interactions | 5.68e-06 | 157 | 164 | 9 | int:RRP15 | |
| Interaction | CDC16 interactions | TCOF1 MAGIX TRPS1 ZNF318 LATS2 ATXN1 ANLN NEMF BUB1 USP54 ZNF281 | 5.70e-06 | 246 | 164 | 11 | int:CDC16 |
| Interaction | XRCC6 interactions | NPM1 EXOSC10 HYOU1 RBBP6 AHCTF1 GPATCH1 SMURF1 YTHDC2 XPC ZNF318 XRCC1 RFC1 CHAMP1 SART1 USP14 BPTF NFATC2 ANLN ZNF638 KMT2A ZNF281 DNMT1 | 6.60e-06 | 928 | 164 | 22 | int:XRCC6 |
| Interaction | SRSF4 interactions | RBBP6 SMURF1 RBM28 GPATCH8 TOE1 HP1BP3 SART1 USP14 BPTF RBM19 ZNF638 KMT2A | 6.64e-06 | 300 | 164 | 12 | int:SRSF4 |
| Interaction | RPS24 interactions | NUSAP1 NPM1 NCAPD3 EXOSC10 GNL3L ERCC6 SMURF1 RPL14 RBM28 ZC3H3 HP1BP3 USP14 NOP14 ANLN RBM19 ANKRD11 | 6.98e-06 | 529 | 164 | 16 | int:RPS24 |
| Interaction | PARP1 interactions | NPM1 PDS5B ERCC6 MAGED1 HYOU1 YTHDC2 XPC RPL14 XRCC1 RBM28 RFC1 MBD3 TOE1 HP1BP3 SART1 USP14 BPTF PHC3 NOP14 BRD2 NFATC2 ANLN RBM19 SMARCC1 KIF2A ZNF281 DNMT1 | 7.87e-06 | 1316 | 164 | 27 | int:PARP1 |
| Interaction | KDM1A interactions | ZNF280D TRPS1 APC ZDBF2 ZNF318 CHAMP1 MBD3 PHC3 RCOR1 DST PHF20L1 NFATC2 ATXN1 CEP44 BUB1 SMARCC1 SAMD3 TAF6 CAMSAP1 PHF21B KLC1 DNMT1 | 8.21e-06 | 941 | 164 | 22 | int:KDM1A |
| Interaction | FGFBP1 interactions | AHCTF1 WDR46 YTHDC2 RBM28 RFC1 TTF1 HP1BP3 NOP14 RBM19 ZNF638 KMT2A | 8.63e-06 | 257 | 164 | 11 | int:FGFBP1 |
| Interaction | FBXO22 interactions | PDS5B GNL3L ERCC6 YTHDC2 TOE1 HP1BP3 TGOLN2 COPS7A SART1 PI3 LATS2 ANKRD11 KMT2A KIF2A GALNT5 CSPP1 | 9.02e-06 | 540 | 164 | 16 | int:FBXO22 |
| Interaction | DDX23 interactions | NPM1 PDS5B ERCC6 TCOF1 RBBP6 SYNE1 XPC RBM28 GPATCH8 SART1 NOP14 BRD2 RBM19 ANKRD11 ZNF638 | 9.30e-06 | 480 | 164 | 15 | int:DDX23 |
| Interaction | SURF6 interactions | NPM1 YTHDC2 RPL14 RBM28 RFC1 TTF1 ZC3H3 TOE1 TGOLN2 SART1 NOP14 ANLN RBM19 MNDA | 1.07e-05 | 426 | 164 | 14 | int:SURF6 |
| Interaction | H2AZ1 interactions | XPC RFC1 CHAMP1 MBD3 HP1BP3 USP14 BPTF RCOR1 BRD2 MORF4L2 ANLN SMARCC1 TXNDC2 | 1.13e-05 | 371 | 164 | 13 | int:H2AZ1 |
| Interaction | RPL31 interactions | NPM1 PDS5B NCAPD3 EXOSC10 GNL3L TCOF1 SMURF1 YTHDC2 RPL14 RBM28 RFC1 TTF1 TOE1 NOP14 BRD2 ANLN RBM19 ANKRD11 | 1.13e-05 | 680 | 164 | 18 | int:RPL31 |
| Interaction | MTA3 interactions | 1.25e-05 | 173 | 164 | 9 | int:MTA3 | |
| Interaction | TLE3 interactions | CBLL1 MAGED1 RBBP6 GPATCH1 TRPS1 ZNF318 GPATCH8 PHC3 ARID1B ATXN1 KMT2A ZNF281 KLC1 | 1.31e-05 | 376 | 164 | 13 | int:TLE3 |
| Interaction | RCOR1 interactions | NPM1 TRPS1 APC ZDBF2 ZNF318 MBD3 RCOR1 DST NFATC2 CEP44 BUB1 SMARCC1 CAMSAP1 PHF21B KLC1 | 1.31e-05 | 494 | 164 | 15 | int:RCOR1 |
| Interaction | DCTN1 interactions | HYOU1 MAP1A GPATCH1 SMURF1 APC BBS4 YTHDC2 RCOR1 DST ATXN1 CEP44 KIF2A CAMSAP1 CAMSAP2 DYNC1LI2 | 1.40e-05 | 497 | 164 | 15 | int:DCTN1 |
| Interaction | KRR1 interactions | NPM1 WDR46 SMURF1 RBM28 TTF1 ZC3H3 TOE1 HP1BP3 NOP14 ANLN RBM19 KMT2A MNDA | 1.42e-05 | 379 | 164 | 13 | int:KRR1 |
| Interaction | CEP135 interactions | MAGED1 GPATCH1 SIPA1L3 APC TXLNA RCOR1 CEP44 TMEM131 USP54 CAMSAP1 CSPP1 | 1.47e-05 | 272 | 164 | 11 | int:CEP135 |
| Interaction | PAK1IP1 interactions | 1.50e-05 | 135 | 164 | 8 | int:PAK1IP1 | |
| Interaction | OASL interactions | 1.50e-05 | 223 | 164 | 10 | int:OASL | |
| Interaction | GATAD2A interactions | 1.55e-05 | 224 | 164 | 10 | int:GATAD2A | |
| Interaction | BRCA2 interactions | CBLL1 NPM1 PDS5B ERCC6 MAGED1 NCKAP5 XRCC1 RCOR1 MORF4L2 KMT2A POLK DYNC1LI2 DNMT1 | 1.63e-05 | 384 | 164 | 13 | int:BRCA2 |
| Interaction | TNIP1 interactions | NUSAP1 NPM1 ATXN2L GNL3L BMP2K TCOF1 RBBP6 SYNE1 AHCTF1 WDR46 RPL14 XRCC1 RBM28 TOE1 HP1BP3 JPH1 SART1 TXLNA RCOR1 DST MORF4L2 IGHG1 CEP44 KIF2A TAF6 | 1.75e-05 | 1217 | 164 | 25 | int:TNIP1 |
| Interaction | TENT4B interactions | 1.76e-05 | 138 | 164 | 8 | int:TENT4B | |
| Interaction | RBBP7 interactions | ERCC6 TCOF1 MBD3 ZFPM2 BPTF RCOR1 PHF20L1 ATXN1 MORF4L2 ANLN SMARCC1 KMT2A ARHGAP25 TAF6 DNMT1 | 1.77e-05 | 507 | 164 | 15 | int:RBBP7 |
| Interaction | H2BC5 interactions | PDS5B TCOF1 MAGIX XPC ADAMTS12 NOP14 DST ATRIP PHF20L1 NEMF SMARCC1 KMT2A | 1.78e-05 | 331 | 164 | 12 | int:H2BC5 |
| Interaction | CUL7 interactions | NPM1 ERCC6 HYOU1 MAP1A TCOF1 MAGIX TRPS1 UBXN6 RPL14 XRCC1 MBD3 HP1BP3 SART1 BPTF LATS2 IGHG1 SPIN2A ZNF638 KIF2A LONRF3 | 1.84e-05 | 845 | 164 | 20 | int:CUL7 |
| Interaction | GRWD1 interactions | NPM1 EXOSC10 RPL14 RBM28 RFC1 KMT2E HP1BP3 SART1 USP14 ANLN RBM19 KMT2A MNDA | 1.92e-05 | 390 | 164 | 13 | int:GRWD1 |
| Interaction | DDX18 interactions | NPM1 TCOF1 SMURF1 RPL14 RBM28 KMT2E TGOLN2 BRD2 ATXN1 ANLN NEMF MNDA | 1.94e-05 | 334 | 164 | 12 | int:DDX18 |
| Interaction | RAD18 interactions | NPM1 RBBP6 SIPA1L3 XPC CHAMP1 TOE1 HP1BP3 SART1 BPTF AFAP1 BRD2 ZNF638 SMARCC1 POLK | 2.33e-05 | 457 | 164 | 14 | int:RAD18 |
| Interaction | DDX21 interactions | DOCK3 NPM1 WDR46 SMURF1 APC YTHDC2 RPL14 RBM28 ZC3H3 HP1BP3 SART1 USP14 NOP14 ATXN1 ANLN RBM19 MNDA KLC1 | 2.34e-05 | 718 | 164 | 18 | int:DDX21 |
| Interaction | NINL interactions | NCAPD3 BMP2K GPATCH1 SIPA1L3 TXLNA RCOR1 LATS2 IGHG1 TMEM131 USP54 CAMSAP1 CAMSAP2 CSPP1 DYNC1LI2 | 2.38e-05 | 458 | 164 | 14 | int:NINL |
| Interaction | ZBTB38 interactions | 2.51e-05 | 145 | 164 | 8 | int:ZBTB38 | |
| Interaction | HDAC2 interactions | NUSAP1 NPM1 ERCC6 BMP2K TRPS1 ZNF318 RPL14 MBD3 ZFPM2 BPTF TXLNA RCOR1 LATS2 PHF20L1 MORF4L2 SMARCC1 KMT2A TAF6 PHF21B DNMT1 | 2.57e-05 | 865 | 164 | 20 | int:HDAC2 |
| Interaction | HNF1B interactions | 2.62e-05 | 190 | 164 | 9 | int:HNF1B | |
| Interaction | ARL4D interactions | 2.64e-05 | 146 | 164 | 8 | int:ARL4D | |
| Interaction | RBM34 interactions | NPM1 RBBP6 WDR46 SMURF1 RPL14 RBM28 TTF1 ZC3H3 TGOLN2 ANLN MNDA | 2.66e-05 | 290 | 164 | 11 | int:RBM34 |
| Interaction | YWHAG interactions | ATXN2L COBLL1 SIPA1L3 MINK1 APC TGOLN2 DST DLC1 LATS2 NFATC2 ATXN1 ANLN IGHG1 MAP4K5 ANKRD11 ZNF638 KMT2A KIF2A ARHGEF4 USP54 CAMSAP1 CAMSAP2 CSPP1 KLC1 DNMT1 | 2.66e-05 | 1248 | 164 | 25 | int:YWHAG |
| Interaction | H1-5 interactions | NPM1 HYOU1 SYNE1 YTHDC2 ZDBF2 RPL14 RBM28 TOE1 HP1BP3 MEPE TXLNA ANLN TCHHL1 RBM19 | 2.69e-05 | 463 | 164 | 14 | int:H1-5 |
| Interaction | BRCA1 interactions | NPM1 UBR2 ATXN2L NCAPD3 EXOSC10 GNL3L ERCC6 HYOU1 ZNF280D TCOF1 RPL14 XRCC1 RBM28 RFC1 HP1BP3 BPTF TXLNA AFAP1 DST ATRIP MORF4L2 ANLN SMARCC1 KIF2A DNMT1 | 2.70e-05 | 1249 | 164 | 25 | int:BRCA1 |
| Interaction | RNF4 interactions | CBLL1 NPM1 PDS5B ATXN2L NCAPD3 MAGED1 BMP2K TCOF1 RBBP6 AHCTF1 TRPS1 XPC RPL14 GPATCH8 KMT2E CHAMP1 HP1BP3 SART1 ARID1B NOP14 PIAS3 ATXN1 ATXN7 MORF4L2 SMARCC1 ZNF281 DNMT1 | 2.76e-05 | 1412 | 164 | 27 | int:RNF4 |
| Interaction | MAGEB2 interactions | NPM1 EXOSC10 RBBP6 YTHDC2 RPL14 RBM28 RFC1 TTF1 TOE1 HP1BP3 ATXN1 RBM19 | 2.99e-05 | 349 | 164 | 12 | int:MAGEB2 |
| Interaction | SQSTM1 interactions | NPM1 MAGED1 BMP2K EARS2 SIPA1L3 MINK1 SMURF1 YTHDC2 RFC1 TOE1 TGOLN2 ADAMTS12 SART1 USP14 BPTF RCOR1 ATXN1 MORF4L2 ANLN MAP4K5 BUB1 USP54 CSPP1 DYNC1LI2 DNMT1 | 3.00e-05 | 1257 | 164 | 25 | int:SQSTM1 |
| Interaction | CDC23 interactions | MAGED1 MAGIX UBXN6 COPS7A RCOR1 LATS2 ATRIP CEP44 ANKRD11 USP54 | 3.02e-05 | 242 | 164 | 10 | int:CDC23 |
| Interaction | SMARCC2 interactions | SAMD9 MBD3 SART1 TXLNA RCOR1 ARID1B BRD2 NFATC2 ATXN1 SMARCC1 KMT2A TAF6 | 3.34e-05 | 353 | 164 | 12 | int:SMARCC2 |
| Interaction | FMR1 interactions | CBLL1 NPM1 ATXN2L MAGED1 TCOF1 RBBP6 APC MBD3 ZFPM2 USP14 ANLN KIF2A CAMSAP2 KLC1 DNMT1 | 3.37e-05 | 536 | 164 | 15 | int:FMR1 |
| Interaction | SMARCA5 interactions | NPM1 ERCC6 COBLL1 MBD3 BPTF RCOR1 BRD2 NFATC2 ATXN1 ANLN SMARCC1 TAF6 DNMT1 | 3.66e-05 | 415 | 164 | 13 | int:SMARCA5 |
| Interaction | SNIP1 interactions | NPM1 ATXN2L TCOF1 AHCTF1 GPATCH1 RPL14 RBM28 GPATCH8 ARID1B NOP14 BRD2 PIAS3 USP54 | 3.84e-05 | 417 | 164 | 13 | int:SNIP1 |
| Interaction | YWHAQ interactions | CBLL1 NPM1 ATXN2L ZNF280D COBLL1 SIPA1L3 MINK1 SMURF1 APC RFC1 DST NFATC2 ATXN1 ANLN IGHG1 ZNF638 KMT2A ARHGEF4 USP54 CAMSAP1 CAMSAP2 KLC1 DNMT1 | 3.85e-05 | 1118 | 164 | 23 | int:YWHAQ |
| Interaction | CCDC137 interactions | 3.92e-05 | 200 | 164 | 9 | int:CCDC137 | |
| Cytoband | Xp11.1 | 7.95e-05 | 4 | 168 | 2 | Xp11.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.67e-04 | 8 | 168 | 2 | chr9q12 | |
| GeneFamily | Tudor domain containing | 7.08e-05 | 37 | 109 | 4 | 780 | |
| GeneFamily | Sterile alpha motif domain containing | 1.91e-04 | 88 | 109 | 5 | 760 | |
| GeneFamily | PHD finger proteins | 2.12e-04 | 90 | 109 | 5 | 88 | |
| GeneFamily | Tudor domain containing|Spindlin family | 3.56e-04 | 5 | 109 | 2 | 1089 | |
| GeneFamily | Ataxins|MJD deubiquinating enzymes | 5.32e-04 | 6 | 109 | 2 | 411 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 109 | 6 | 682 | |
| GeneFamily | Zinc fingers CXXC-type | 2.28e-03 | 12 | 109 | 2 | 136 | |
| GeneFamily | UBX domain containing | 2.69e-03 | 13 | 109 | 2 | 364 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.01e-03 | 53 | 109 | 3 | 532 | |
| GeneFamily | CD molecules|Membrane spanning 4-domains | 5.17e-03 | 18 | 109 | 2 | 958 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NPM1 PDS5B UBR2 ATXN2L ADAM19 SAMD9 RBBP6 SYNE1 TRPS1 GPRIN3 YTHDC2 CST7 RPL14 GPATCH8 KMT2E TGOLN2 ITPR2 BPTF PHC3 RASGRP1 PHF20L1 NFATC2 ATXN1 ATXN7 NEMF ANKRD11 ZNF638 KMT2A ARHGAP25 KIF2A SAMD3 SLC16A7 KLC1 DNMT1 BRWD1 | 1.32e-11 | 1492 | 166 | 35 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B UBR2 BMP2K AHCTF1 APC GPATCH8 BPTF RCOR1 AFAP1 DST DLC1 ATXN1 MAP4K5 ZNF638 TMEM131 KIF2A CAMSAP2 MN1 SLC16A7 KLC1 | 5.41e-07 | 856 | 166 | 20 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | NPM1 UBR2 SP4 GNL3L BMP2K RBBP6 COBLL1 TRPS1 APC BBS4 RBM28 TTF1 ITPR2 RCOR1 ZNF544 ATXN1 MAP4K5 SPIN2A SMARCC1 KMT2A TMEM131 CAMSAP1 SPIN2B SLC16A7 | 7.58e-07 | 1215 | 166 | 24 | M41122 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 5.52e-06 | 200 | 166 | 9 | M4979 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | NPM1 NCAPD3 SP4 MAGED1 ZNF280D SYNE1 AHCTF1 COBLL1 CST7 ZDBF2 ANKRD36C BPTF RASGRP1 NFATC2 ARHGEF9 SLC4A10 KMT2A SAMD3 SLC16A7 BRWD1 | 6.84e-06 | 1012 | 166 | 20 | M40864 |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_24HR | 1.32e-05 | 48 | 166 | 5 | MM1181 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NUSAP1 NPM1 PDS5B AHCTF1 APC RFC1 ITPR2 BPTF PHF20L1 ANLN NEMF ZNF638 POLK CSPP1 SLC16A7 | 1.98e-05 | 656 | 166 | 15 | M18979 |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | NPM1 ATXN2L SAMD9 SYNE1 CST7 RPL14 KMT2E HP1BP3 TGOLN2 BPTF RASGRP1 BRD2 NFATC2 KMT2A ARHGAP25 SLC16A7 KLC1 DNMT1 | 2.04e-05 | 911 | 166 | 18 | M40038 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NPM1 PDS5B UBR2 EXOSC10 ADAM19 AFF2 TCOF1 RBBP6 APC XPC ZNF318 RPL14 RFC1 TOE1 TGOLN2 BPTF RASGRP1 GJA8 RCOR1 NOP14 ARHGAP25 PTTG2 DNMT1 | 2.48e-05 | 1394 | 166 | 23 | M9585 |
| Coexpression | ISHIDA_E2F_TARGETS | 2.58e-05 | 55 | 166 | 5 | MM1264 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RBBP6 AHCTF1 UBXN6 TRMO GPRIN3 ZDBF2 RFC1 LATS2 PHF20L1 ATXN1 ATXN7 PCIF1 ZNF518B LONRF3 BRWD1 | 2.99e-05 | 680 | 166 | 15 | M41089 |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 3.87e-05 | 197 | 166 | 8 | M5495 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 4.15e-05 | 199 | 166 | 8 | M9410 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 4.15e-05 | 199 | 166 | 8 | M6030 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 4.15e-05 | 199 | 166 | 8 | M9124 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | CBLL1 ATXN2L SYNE1 ATXN7 IGHG1 MAP4K5 RBM19 KMT2A KIF2A CAMSAP1 MNDA | 5.08e-05 | 399 | 166 | 11 | M40939 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | NUSAP1 NPM1 SAMD9 RBBP6 SMURF1 APC RFC1 MORF4L2 ANLN MAP4K5 NEMF KIF2A CAMSAP1 DNMT1 BRWD1 | 5.81e-05 | 721 | 166 | 15 | M10237 |
| Coexpression | CHANDRAN_METASTASIS_UP | 5.87e-05 | 209 | 166 | 8 | M16036 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK3 SP4 CACNB3 AFF2 BRSK2 SMURF1 APC GPRIN3 ZNF318 KMT2E ZFPM2 JPH1 KIAA1549L LRFN5 SBF2 CAMSAP2 PLXNA1 KLC1 BRWD1 | 7.88e-05 | 1106 | 166 | 19 | M39071 |
| Coexpression | TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING | 9.69e-05 | 288 | 166 | 9 | MM3751 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NUSAP1 DOCK3 NCAPD3 CACNB3 MAGED1 BRSK2 RFC1 PTTG3P MORF4L2 ANLN SMARCC1 CAMSAP1 PTTG2 DNMT1 | 1.15e-04 | 680 | 166 | 14 | MM456 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 1.35e-04 | 176 | 166 | 7 | M8952 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.40e-04 | 177 | 166 | 7 | M39245 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN | 1.45e-04 | 178 | 166 | 7 | M6728 | |
| Coexpression | FISCHER_DREAM_TARGETS | NUSAP1 PDS5B NCAPD3 SP4 TCOF1 RBBP6 AHCTF1 WDR46 XRCC1 RFC1 TTF1 TOE1 ANLN BUB1 SMARCC1 KIF2A DNMT1 | 1.49e-04 | 969 | 166 | 17 | M149 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NUSAP1 PDS5B NCAPD3 EXOSC10 TCOF1 AHCTF1 XRCC1 RBM28 ANKRD36C RFC1 CHAMP1 TTF1 TOE1 USP14 RCOR1 MORF4L2 ANLN BUB1 TAF6 CSPP1 DNMT1 | 1.50e-04 | 1363 | 166 | 21 | M45782 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 1.55e-04 | 180 | 166 | 7 | M8127 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 1.57e-04 | 80 | 166 | 5 | M15368 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 1.58e-04 | 43 | 166 | 4 | MM1204 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 1.61e-04 | 181 | 166 | 7 | M8187 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.98e-04 | 84 | 166 | 5 | M13008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | UBR2 BPTF RCOR1 AFAP1 DST DLC1 MAP4K5 ZNF638 TMEM131 KIF2A CAMSAP2 | 1.99e-04 | 466 | 166 | 11 | M13522 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.02e-04 | 250 | 166 | 8 | M11318 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP | 2.03e-04 | 188 | 166 | 7 | M8452 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_LB_UP | 2.24e-04 | 47 | 166 | 4 | M14744 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | ATXN2L RBBP6 AHCTF1 YTHDC2 ZNF318 ACBD6 HP1BP3 PHC3 PHF20L1 SLC16A7 DYNC1LI2 | 2.30e-04 | 474 | 166 | 11 | M40991 |
| Coexpression | GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP | 2.38e-04 | 193 | 166 | 7 | M7395 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 2.46e-04 | 194 | 166 | 7 | M7467 | |
| Coexpression | GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN | 2.54e-04 | 195 | 166 | 7 | M4917 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN | 2.62e-04 | 196 | 166 | 7 | M10002 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.70e-04 | 197 | 166 | 7 | M5351 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN | 2.87e-04 | 199 | 166 | 7 | M8259 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN | 2.87e-04 | 199 | 166 | 7 | M3709 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.87e-04 | 199 | 166 | 7 | M5893 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN | 2.87e-04 | 199 | 166 | 7 | M7976 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 2.96e-04 | 200 | 166 | 7 | M8088 | |
| Coexpression | GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP | 2.96e-04 | 200 | 166 | 7 | M5819 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 2.96e-04 | 200 | 166 | 7 | M8312 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.96e-04 | 200 | 166 | 7 | M9889 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 2.96e-04 | 200 | 166 | 7 | M8427 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP | 2.96e-04 | 200 | 166 | 7 | M3850 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN | 2.96e-04 | 200 | 166 | 7 | M3877 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP | 2.96e-04 | 200 | 166 | 7 | M3878 | |
| Coexpression | GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP | 2.96e-04 | 200 | 166 | 7 | M7352 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 2.96e-04 | 200 | 166 | 7 | M5005 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 2.96e-04 | 200 | 166 | 7 | M6611 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 3.31e-04 | 269 | 166 | 8 | M41203 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 3.54e-04 | 206 | 166 | 7 | M2817 | |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 | 3.57e-04 | 53 | 166 | 4 | M10169 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 3.75e-04 | 208 | 166 | 7 | MM581 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | NUSAP1 CCDC169 NCAPD3 TCOF1 JPH1 PTTG3P ATRIP ANLN BUB1 KIF2A MN1 PTTG2 | 3.86e-04 | 588 | 166 | 12 | M38992 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CBLL1 NUSAP1 DOCK3 NPM1 SP4 GNL3L AFF2 ZNF280D TCOF1 RBBP6 AHCTF1 TRPS1 WDR46 APC ZDBF2 RFC1 TTF1 BPTF KIAA1549L ANLN NEMF BUB1 SPIN2A SMARCC1 KIF2A ZNF518B CAMSAP1 ZNF281 CSPP1 PHF21B DNMT1 BRWD1 | 5.04e-08 | 1459 | 162 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CBLL1 NUSAP1 NPM1 SP4 GNL3L ZNF280D TCOF1 RBBP6 AHCTF1 TRPS1 WDR46 APC ZDBF2 RFC1 TTF1 BPTF KIAA1549L ANLN NEMF BUB1 SPIN2A SMARCC1 KIF2A ZNF518B CAMSAP1 ZNF281 CSPP1 DNMT1 BRWD1 | 8.22e-08 | 1257 | 162 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | NUSAP1 NPM1 EXOSC10 APC SART1 NOP14 DST PHF20L1 ANLN NEMF BUB1 ANKRD11 ZNF638 SMARCC1 TMEM131 | 3.26e-06 | 469 | 162 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | NPM1 ZDBF2 JPH1 DST KIAA1549L PHF20L1 ANLN NEMF ANKRD11 ZNF638 PHF21B | 5.07e-06 | 259 | 162 | 11 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | NPM1 ERCC6 AHCTF1 ZDBF2 DELE1 NOP14 PHF20L1 ANLN NEMF BUB1 ANKRD11 ZNF638 SMARCC1 ZNF518B DNMT1 | 1.47e-05 | 532 | 162 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | NUSAP1 PDS5B ATXN2L EXOSC10 GNL3L ZNF280D GPATCH1 APC ITPR2 SART1 BPTF ATRIP TMEM131 CSPP1 BRWD1 | 2.89e-05 | 564 | 162 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 7.46e-05 | 92 | 162 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | CBLL1 NUSAP1 NPM1 AFF2 ZNF280D SYNE1 TRPS1 APC TOE1 RCOR1 TMEM131 BRWD1 | 1.24e-04 | 432 | 162 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NUSAP1 NPM1 ZNF280D MAP1A TRPS1 BRSK2 APC NCKAP5 ZDBF2 TDRD1 TTF1 KIAA1549L BUB1 SMARCC1 KIF2A CAMSAP1 ZNF281 CSPP1 PHF21B BRWD1 | 1.72e-04 | 1060 | 162 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CBLL1 NUSAP1 PDS5B SP4 ZNF280D APC NCKAP5 ZDBF2 GPATCH8 BPTF TAF6 CSPP1 PHF21B DYNC1LI2 | 1.95e-04 | 595 | 162 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | NPM1 SYNE1 GPRIN3 CST7 ANKRD36C KMT2E RASGRP1 NFATC2 KMT2A SAMD3 | 4.25e-09 | 197 | 168 | 10 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | NUSAP1 NPM1 ADAM19 SYNE1 GPRIN3 CST7 RASGRP1 NFATC2 BUB1 SAMD3 | 4.68e-09 | 199 | 168 | 10 | 928e346b0f31d991ebab12fefb4eb9f4249e601d |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.90e-08 | 191 | 168 | 9 | b9ef6d82b86271b7e0875a399bb9aae84ef5bad3 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.12e-08 | 192 | 168 | 9 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.39e-08 | 197 | 168 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.39e-08 | 197 | 168 | 9 | 59b1fb93a39dcf8c994d2b7dc2906dae74c57527 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.39e-08 | 197 | 168 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.97e-08 | 199 | 168 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.27e-08 | 200 | 168 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.56e-07 | 168 | 168 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.91e-07 | 183 | 168 | 8 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.41e-07 | 130 | 168 | 7 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-07 | 191 | 168 | 8 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.93e-07 | 195 | 168 | 8 | 42382653e977714bff453bece26a6cd66ea2cc1f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.93e-07 | 195 | 168 | 8 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.24e-07 | 196 | 168 | 8 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | Severe-Lymphoid-T-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 8.56e-07 | 197 | 168 | 8 | 00d884ec591f63a345d7fd0a6b368f9da4b4c6ce | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 8.56e-07 | 197 | 168 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.89e-07 | 198 | 168 | 8 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.89e-07 | 198 | 168 | 8 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | Healthy_Control-Lymphoid-T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.24e-07 | 199 | 168 | 8 | f22438fc9c02d0a4d7c936f9420b913aca851ea1 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.24e-07 | 199 | 168 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.24e-07 | 199 | 168 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Severe-Lymphoid-T|Severe / Condition, Lineage, Cell class and cell subclass | 9.24e-07 | 199 | 168 | 8 | ad2be3739721b7bfc2bd50eafd01d4325b01016e | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.59e-07 | 200 | 168 | 8 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 164 | 168 | 7 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 164 | 168 | 7 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 164 | 168 | 7 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.66e-06 | 175 | 168 | 7 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.84e-06 | 176 | 168 | 7 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.81e-06 | 181 | 168 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-06 | 185 | 168 | 7 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-06 | 186 | 168 | 7 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.45e-06 | 188 | 168 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.71e-06 | 189 | 168 | 7 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.71e-06 | 189 | 168 | 7 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.98e-06 | 190 | 168 | 7 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | Healthy_Control-Lymphoid-T-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.55e-06 | 192 | 168 | 7 | 36b6ea21b0b1342f2dcac4dcaf359b6c772203f7 | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 8.55e-06 | 192 | 168 | 7 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.55e-06 | 192 | 168 | 7 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.55e-06 | 192 | 168 | 7 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.14e-06 | 194 | 168 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.14e-06 | 194 | 168 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.46e-06 | 195 | 168 | 7 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.46e-06 | 195 | 168 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.46e-06 | 195 | 168 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.78e-06 | 196 | 168 | 7 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 9.78e-06 | 196 | 168 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.78e-06 | 196 | 168 | 7 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | PSB-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.78e-06 | 196 | 168 | 7 | 7b5c2a4cdea9a944f83bfc2c493d3076c3daaeaa | |
| ToppCell | Severe-Lymphoid-T-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.01e-05 | 197 | 168 | 7 | 0489e0b08f3c3ef90b166ea2f26a0b2b12bd2077 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 168 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 197 | 168 | 7 | adc7bf2120fad4aea58123d882a8cf18ed4174d0 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-05 | 197 | 168 | 7 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 168 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-05 | 197 | 168 | 7 | 4cec48e202f4583c9328d4b722c49ed3471ec173 | |
| ToppCell | BL-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-05 | 197 | 168 | 7 | fb70918867fbd111bb192a797dcafed5f39ea299 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 197 | 168 | 7 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Influenza_Severe-NK|Influenza_Severe / Disease group and Cell class | 1.01e-05 | 197 | 168 | 7 | d0f58ee4c02573d214deb210bb7efd3d6118f267 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.01e-05 | 197 | 168 | 7 | c1c47db5e8d1b248bc192556275edd1ce168a953 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 197 | 168 | 7 | 927bf36bad3bcb7346c13b660777c1c0de7dc322 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 197 | 168 | 7 | 3e09158507df08c08e08613ce23617206280c911 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-05 | 197 | 168 | 7 | fef3ccfadc06d11244b71395b0a13280841dd368 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 197 | 168 | 7 | e133bd09efc6d7f539fc1a1ac7a945f07103d6e6 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-05 | 198 | 168 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Healthy_Control-Lymphoid|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.04e-05 | 198 | 168 | 7 | c176c583f426e4373daca4a696ab8832e838cfbf | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.04e-05 | 198 | 168 | 7 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | Mild_COVID-19-T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.04e-05 | 198 | 168 | 7 | 329eb0fc0bda3d66765de0393290dccb3e15c311 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-05 | 198 | 168 | 7 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 198 | 168 | 7 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | severe_influenza-NK|severe_influenza / disease group, cell group and cell class (v2) | 1.04e-05 | 198 | 168 | 7 | d431beb870ff5e165d98febfb27049d729e37dc8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 198 | 168 | 7 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-05 | 198 | 168 | 7 | a3c62d7c0ec769767a4697d1aa09880a106abc85 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.08e-05 | 199 | 168 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 199 | 168 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Mild-Lymphoid-T-CD8_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.08e-05 | 199 | 168 | 7 | 27cb0b58bf9d2a5ff6cca1720d660780ce12f9d9 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.08e-05 | 199 | 168 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-05 | 199 | 168 | 7 | 9936196214a12502ebfaf152d39d40a2ed83c72d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-05 | 199 | 168 | 7 | 28cec7122b143373f1c7c94acf35bf8f896e0d57 | |
| ToppCell | Severe_COVID-19-T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.08e-05 | 199 | 168 | 7 | ace179b860513179e9275ed40ae1985a98385026 | |
| ToppCell | Mild-Lymphoid|Mild / Condition, Lineage, Cell class and cell subclass | 1.08e-05 | 199 | 168 | 7 | 5bf1bf2741ab374b1a914fc88ef805903d1941ca | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.08e-05 | 199 | 168 | 7 | c8a2c94809b2134b51bb9868b63cb280b490f3fe | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-05 | 200 | 168 | 7 | 87c8a4aed9dcfe895d3963708326067e057473c0 | |
| ToppCell | severe-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-05 | 200 | 168 | 7 | 8a849d0ef244aa2666da2d31bd0731fb04e40911 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD8+_Tem|Influenza_Severe / Disease, condition lineage and cell class | 1.11e-05 | 200 | 168 | 7 | 06d80a7aff4b168b131c80750c335215b0fcff3f | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.11e-05 | 200 | 168 | 7 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-05 | 200 | 168 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-05 | 200 | 168 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK|Influenza_Severe / Disease, condition lineage and cell class | 1.11e-05 | 200 | 168 | 7 | 04ac14414d550b14dc46d682e7af9dd43982211a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Mild-Lymphoid-T|Mild / Condition, Lineage, Cell class and cell subclass | 1.11e-05 | 200 | 168 | 7 | 94326b61f4eef47e23891becf98103c8145e5f51 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.42e-05 | 138 | 168 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.83e-05 | 156 | 168 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.15e-05 | 159 | 168 | 6 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 159 | 168 | 6 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 159 | 168 | 6 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.48e-06 | 49 | 105 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.44e-06 | 50 | 105 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.21e-04 | 50 | 105 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.21e-04 | 50 | 105 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 67. | 3.69e-04 | 227 | 105 | 9 | MODULE_67 | |
| Computational | rRNA processing and DNA repair. | 6.64e-04 | 18 | 105 | 3 | MODULE_392 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | PDS5B GNL3L RBBP6 GPATCH8 TTF1 BPTF RASGRP1 DLC1 ATXN1 ANKRD11 KMT2A CSPP1 SLC16A7 DYNC1LI2 | 3.87e-11 | 177 | 163 | 14 | 985_DN |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | CACNB3 HYOU1 APC TRMO DELE1 ZC3H3 HP1BP3 MAP4K5 PCIF1 ASPSCR1 CAMSAP2 | 1.97e-07 | 198 | 163 | 11 | 5314_DN |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; PC3; HT_HG-U133A | 1.42e-06 | 194 | 163 | 10 | 7086_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 8.46e-06 | 187 | 163 | 9 | 4323_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.00e-05 | 191 | 163 | 9 | 2857_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.05e-05 | 192 | 163 | 9 | 3188_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.14e-05 | 194 | 163 | 9 | 4727_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 2936_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; HL60; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 2925_DN | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.29e-05 | 197 | 163 | 9 | 7484_UP | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 1.29e-05 | 197 | 163 | 9 | 371_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.29e-05 | 197 | 163 | 9 | 2052_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.29e-05 | 197 | 163 | 9 | 1012_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.39e-05 | 199 | 163 | 9 | 4537_DN | |
| Drug | Clorgyline | 2.93e-05 | 168 | 163 | 8 | ctd:D003010 | |
| Drug | torcetrapib | AFF2 PRICKLE1 RBBP6 AHCTF1 TGOLN2 ITPR2 PHC3 DST ANKRD11 SMARCC1 KMT2A | 3.76e-05 | 342 | 163 | 11 | ctd:C483909 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.42e-05 | 178 | 163 | 8 | 1672_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 4.60e-05 | 179 | 163 | 8 | 332_DN | |
| Drug | scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A | 4.60e-05 | 179 | 163 | 8 | 6901_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 4.98e-05 | 181 | 163 | 8 | 1791_DN | |
| Drug | lithium indium | 5.09e-05 | 2 | 163 | 2 | CID011116062 | |
| Drug | norkurarinol | 5.09e-05 | 2 | 163 | 2 | ctd:C572712 | |
| Drug | scandium phosphate | 5.09e-05 | 2 | 163 | 2 | CID006365269 | |
| Drug | kurarinone | 5.09e-05 | 2 | 163 | 2 | ctd:C411319 | |
| Drug | ascaridole | 5.09e-05 | 2 | 163 | 2 | ctd:C043372 | |
| Drug | Carbazoles | 5.09e-05 | 2 | 163 | 2 | ctd:D002227 | |
| Drug | rubidium nitrate | 5.09e-05 | 2 | 163 | 2 | CID000025731 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.17e-05 | 182 | 163 | 8 | 3887_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.59e-05 | 184 | 163 | 8 | 2321_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 6.75e-05 | 189 | 163 | 8 | 5084_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 7.00e-05 | 190 | 163 | 8 | 4114_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 6020_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A | 7.81e-05 | 193 | 163 | 8 | 1363_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 8.10e-05 | 194 | 163 | 8 | 6741_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 5325_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 7400_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A | 8.70e-05 | 196 | 163 | 8 | 1423_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 5595_DN | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 6629_DN | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 3544_DN | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 3145_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.01e-05 | 197 | 163 | 8 | 1003_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 1810_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 1314_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 6974_DN | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 4947_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 4584_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 6668_DN | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 5306_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 4729_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 3990_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 6468_DN | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 7203_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; HL60; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 2562_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 2077_DN | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 2083_DN | |
| Disease | low density lipoprotein particle size measurement | 1.70e-05 | 58 | 162 | 5 | EFO_0008593 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.45e-05 | 12 | 162 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.51e-05 | 111 | 162 | 6 | EFO_0004530, EFO_0008595 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.73e-05 | 293 | 162 | 9 | C1708349 | |
| Disease | Intellectual Disability | SYNE1 BRSK2 APC RBM28 KMT2E ACBD6 CHAMP1 BPTF SLC4A10 TAF6 MN1 | 3.93e-05 | 447 | 162 | 11 | C3714756 |
| Disease | Stomach Neoplasms | 4.14e-05 | 297 | 162 | 9 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 4.47e-05 | 300 | 162 | 9 | C0024623 | |
| Disease | red blood cell density measurement | SP4 BMP2K COBLL1 TRPS1 RFC1 ZFPM2 COPS7A GJA8 ARID1B DST PHF20L1 MAP4K5 SBF2 PCIF1 KIF2A | 1.09e-04 | 880 | 162 | 15 | EFO_0007978 |
| Disease | Adenocarcinoma of lung (disorder) | 1.49e-04 | 206 | 162 | 7 | C0152013 | |
| Disease | Neurodevelopmental Disorders | 1.65e-04 | 93 | 162 | 5 | C1535926 | |
| Disease | palmitoleoyl-protein carboxylesterase NOTUM measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0802842 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.79e-04 | 51 | 162 | 4 | EFO_0022331 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.07e-04 | 153 | 162 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | pulse pressure measurement | COBLL1 TRPS1 DELE1 ZNF318 GPATCH8 ANKRD36C ZFPM2 ARID1B AFAP1 DLC1 LATS2 KIAA1549L NFATC2 ATXN1 ATXN7 SBF2 ANKRD11 ZNF638 DNMT1 | 2.41e-04 | 1392 | 162 | 19 | EFO_0005763 |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.49e-04 | 224 | 162 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | triglycerides in LDL measurement | 2.57e-04 | 56 | 162 | 4 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.57e-04 | 56 | 162 | 4 | EFO_0022235 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.85e-04 | 229 | 162 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | platelet component distribution width | PDS5B BMP2K MAGIX SYNE1 COBLL1 TRMO RIPOR3 ZFPM2 DLC1 TBC1D14 KIF2A POLK BRWD1 | 2.87e-04 | 755 | 162 | 13 | EFO_0007984 |
| Disease | Cerebellar Ataxia | 2.96e-04 | 5 | 162 | 2 | C0007758 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.21e-04 | 166 | 162 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | monocyte count | AFF2 BMP2K MS4A6E TRPS1 RIPOR3 IQCN TDRD1 ZFPM2 RCOR1 BRD2 ATXN1 MAP4K5 TBC1D14 MS4A14 ARHGAP25 ATP1A4 MN1 DNMT1 | 3.58e-04 | 1320 | 162 | 18 | EFO_0005091 |
| Disease | triglycerides in small VLDL measurement | 3.58e-04 | 61 | 162 | 4 | EFO_0022145 | |
| Disease | triglycerides in small HDL measurement | 3.81e-04 | 62 | 162 | 4 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 3.81e-04 | 62 | 162 | 4 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 3.81e-04 | 62 | 162 | 4 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.81e-04 | 62 | 162 | 4 | EFO_0022339 | |
| Disease | Micronuclei, Chromosome-Defective | 3.85e-04 | 26 | 162 | 3 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 3.85e-04 | 26 | 162 | 3 | C1449862 | |
| Disease | Colorectal cancer | 4.31e-04 | 27 | 162 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 4.31e-04 | 27 | 162 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 4.31e-04 | 27 | 162 | 3 | cv:C0009404 | |
| Disease | low density lipoprotein cholesterol measurement, body mass index | 4.43e-04 | 6 | 162 | 2 | EFO_0004340, EFO_0004611 | |
| Disease | Alzheimer disease, educational attainment | 4.49e-04 | 247 | 162 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | triglycerides in small LDL measurement | 4.57e-04 | 65 | 162 | 4 | EFO_0022323 | |
| Disease | total lipids in small VLDL | 5.13e-04 | 67 | 162 | 4 | EFO_0022148 | |
| Disease | triglycerides in very small VLDL measurement | 5.42e-04 | 68 | 162 | 4 | EFO_0022144 | |
| Disease | colorectal cancer (is_implicated_in) | 5.58e-04 | 121 | 162 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | cervical cancer (is_implicated_in) | 5.91e-04 | 30 | 162 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement | 6.08e-04 | 260 | 162 | 7 | EFO_0008317 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 6.82e-04 | 346 | 162 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | fatty acid measurement | 7.16e-04 | 436 | 162 | 9 | EFO_0005110 | |
| Disease | calcium measurement | MAP1A COBLL1 GPRIN3 ZNF318 ZFPM2 ARID1B MAP4K5 TMEM131 ATP1A4 POLK ZNF281 | 7.35e-04 | 628 | 162 | 11 | EFO_0004838 |
| Disease | free cholesterol to total lipids in large LDL percentage | 7.47e-04 | 74 | 162 | 4 | EFO_0022280 | |
| Disease | gout | 7.72e-04 | 196 | 162 | 6 | EFO_0004274 | |
| Disease | Tinnitus | 7.73e-04 | 130 | 162 | 5 | HP_0000360 | |
| Disease | Acute erythroleukemia - M6a subtype | 8.21e-04 | 8 | 162 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 8.21e-04 | 8 | 162 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 8.21e-04 | 8 | 162 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 8.21e-04 | 8 | 162 | 2 | C2930974 | |
| Disease | brain measurement, neuroimaging measurement | ATXN2L GPATCH1 TRPS1 BRSK2 NCKAP5 GPATCH8 BPTF AFAP1 ATXN7 SLC4A10 | 9.65e-04 | 550 | 162 | 10 | EFO_0004346, EFO_0004464 |
| Disease | cholesterol in large HDL measurement | 1.00e-03 | 80 | 162 | 4 | EFO_0021900 | |
| Disease | cholesterol in small HDL measurement | 1.02e-03 | 36 | 162 | 3 | EFO_0022226 | |
| Disease | alcohol drinking | 1.05e-03 | 81 | 162 | 4 | EFO_0004329 | |
| Disease | corneodesmosin measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0801499 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 1.05e-03 | 9 | 162 | 2 | C4225275 | |
| Disease | serum alanine aminotransferase measurement | PDS5B ATXN2L HYOU1 COBLL1 TRPS1 IQCN BPTF AFAP1 MAP4K5 LUZP2 ARHGEF4 DNMT1 BRWD1 | 1.06e-03 | 869 | 162 | 13 | EFO_0004735 |
| Disease | neuroimaging measurement, brain volume measurement | 1.06e-03 | 286 | 162 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.24e-03 | 215 | 162 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | alcohol consumption measurement | ATXN2L ZNF280D COBLL1 TRPS1 NCKAP5 RFC1 COPS7A NFATC2 ATXN1 MAP4K5 LRFN5 SLC4A10 ANKRD11 ASPSCR1 KIF2A SLC16A7 | 1.39e-03 | 1242 | 162 | 16 | EFO_0007878 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.40e-03 | 220 | 162 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.53e-03 | 224 | 162 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | body fat percentage | 1.56e-03 | 488 | 162 | 9 | EFO_0007800 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.59e-03 | 42 | 162 | 3 | EFO_0022255 | |
| Disease | level of Ceramide (d40:1) in blood serum | 1.59e-03 | 11 | 162 | 2 | OBA_2045185 | |
| Disease | neutrophil count | UBR2 ADAM19 RIPOR3 KMT2E ZFPM2 TGOLN2 ITPR2 GJA8 ATXN1 ATXN7 MAP4K5 SBF2 TBC1D14 ANKRD11 ARHGAP25 ATP1A4 DNMT1 | 1.61e-03 | 1382 | 162 | 17 | EFO_0004833 |
| Disease | Childhood Medulloblastoma | 1.71e-03 | 43 | 162 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.71e-03 | 43 | 162 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.71e-03 | 43 | 162 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.71e-03 | 43 | 162 | 3 | C0751291 | |
| Disease | triglycerides in large LDL measurement | 1.71e-03 | 43 | 162 | 3 | EFO_0022319 | |
| Disease | Adult Medulloblastoma | 1.71e-03 | 43 | 162 | 3 | C0278876 | |
| Disease | immunoglobulin isotype switching measurement | 1.82e-03 | 44 | 162 | 3 | EFO_0010128 | |
| Disease | hepatocyte growth factor measurement | 1.82e-03 | 44 | 162 | 3 | EFO_0006903 | |
| Disease | neutrophil percentage of leukocytes | UBR2 ADAM19 COBLL1 MINK1 TGOLN2 ATXN1 MAP4K5 TBC1D14 TMEM131 ARHGAP25 | 2.07e-03 | 610 | 162 | 10 | EFO_0007990 |
| Disease | gallbladder cancer (is_implicated_in) | 2.25e-03 | 13 | 162 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | urate measurement, bone density | SYNE1 AHCTF1 RIPOR3 ITPR2 USP14 LATS2 MAP4K5 ANKRD11 LUZP2 ARHGAP25 | 2.31e-03 | 619 | 162 | 10 | EFO_0003923, EFO_0004531 |
| Disease | iron biomarker measurement | 2.34e-03 | 48 | 162 | 3 | EFO_0004461 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0008212 | |
| Disease | Medulloblastoma | 2.64e-03 | 50 | 162 | 3 | C0025149 | |
| Disease | C-reactive protein measurement | DOCK3 UBR2 ATXN2L ADAM19 MAP1A COBLL1 TRPS1 RIPOR3 YTHDC2 CST7 ZFPM2 BPTF MAP4K5 PCIF1 DYNC1LI2 | 2.73e-03 | 1206 | 162 | 15 | EFO_0004458 |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.79e-03 | 51 | 162 | 3 | EFO_0022302 | |
| Disease | BMI-adjusted leptin measurement | 3.00e-03 | 15 | 162 | 2 | EFO_0007793 | |
| Disease | anemia (implicated_via_orthology) | 3.00e-03 | 15 | 162 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.11e-03 | 53 | 162 | 3 | EFO_0022340 | |
| Disease | triglycerides in HDL measurement | 3.11e-03 | 53 | 162 | 3 | EFO_0022317 | |
| Disease | Epilepsy | 3.11e-03 | 109 | 162 | 4 | C0014544 | |
| Disease | triglycerides in medium HDL measurement | 3.28e-03 | 54 | 162 | 3 | EFO_0022321 | |
| Disease | Congenital total cataract | 3.42e-03 | 16 | 162 | 2 | C0266539 | |
| Disease | Chromosome Aberrations | 3.42e-03 | 16 | 162 | 2 | C0008625 | |
| Disease | cystatin-F measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0008104 | |
| Disease | Autosome Abnormalities | 3.42e-03 | 16 | 162 | 2 | C0004403 | |
| Disease | leptin measurement, type 2 diabetes mellitus | 3.42e-03 | 16 | 162 | 2 | EFO_0005000, MONDO_0005148 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.42e-03 | 16 | 162 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | triglycerides in medium VLDL measurement | 3.46e-03 | 55 | 162 | 3 | EFO_0022155 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.46e-03 | 55 | 162 | 3 | EFO_0022234 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 3.46e-03 | 55 | 162 | 3 | EFO_0022288 | |
| Disease | triglycerides in large VLDL measurement | 3.64e-03 | 56 | 162 | 3 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 3.64e-03 | 56 | 162 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.64e-03 | 56 | 162 | 3 | EFO_0022333 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNIKPGNNVRPAKSK | 126 | Q9BXT4 | |
| KGTKIQTPAAPKQVF | 846 | Q15361 | |
| KRPSTSEVNNVNPKK | 176 | Q6N043 | |
| NITAKNPAKSNTSKP | 551 | Q6N043 | |
| QFPVSTESQKPRQKK | 11 | Q96RK4 | |
| KPKKSKSGQDPQQEQ | 281 | Q9BZE9 | |
| AKNPEPQKATAPVKD | 331 | Q6UB99 | |
| DGKFSPIQEKSPKQA | 651 | O43683 | |
| APGTNQRQPSKKASK | 246 | Q9UBW8 | |
| NPAKQKTVSAKRGPV | 186 | A6NNP5 | |
| RSPPPSLAKQKQKQA | 151 | P54284 | |
| CPKKSNGRPNETDIK | 1001 | P26358 | |
| ANPTFKLQTPQGKRK | 761 | Q9H013 | |
| GPVPVNSAAVLKKSQ | 691 | Q8N556 | |
| KVKTNASQVPAEPKE | 571 | P51816 | |
| QAAPSPVTNVKKGKI | 466 | P54756 | |
| CKKRAKNPVAPTENN | 591 | O95267 | |
| SKQQVTGKPKAVGRP | 631 | Q9NR80 | |
| SQQRKKISSGKSEPP | 131 | Q9C0F1 | |
| VFSTGDTKKQPKLQP | 1236 | Q8NFD5 | |
| NPQIPEKKGKEANTG | 126 | Q9BR61 | |
| KNGSVKKGQPVDPAS | 691 | P54253 | |
| ANPIKNGKTSPASKD | 706 | Q9NSY1 | |
| PVKGTEANGKKPSQQ | 1476 | Q12830 | |
| PVPGSKNNSQDHKVK | 1056 | Q5T5Y3 | |
| VPDQKLNQPSAEKTK | 586 | Q53SF7 | |
| KKKRRAQQAPPQDSS | 66 | Q9Y463 | |
| PKRKKFPASNISVND | 1051 | Q03468 | |
| NKGTISNGKNPPTLK | 1006 | P58397 | |
| KSTLNPNAKEFNPTK | 656 | Q8WWM7 | |
| KVPKQKGVNSARSVP | 451 | O43307 | |
| TPAKSPGKAASVKQR | 461 | Q5SSJ5 | |
| SVKQRGSKPAPKVSA | 471 | Q5SSJ5 | |
| PVKKSIRDTPAKNAQ | 191 | P06748 | |
| KEETNGPSNQKPVKS | 446 | Q9UKL0 | |
| REKNVPTTKGAPKNT | 366 | Q9Y4C8 | |
| QSKVPPEQKRKAGST | 631 | Q9NW13 | |
| REITKKLGNPKQPTN | 581 | Q9NTI5 | |
| RAQTQGPVKAETPKA | 311 | Q9H0B3 | |
| NVRDGVPPTSKKKRQ | 331 | Q14571 | |
| PVQDGTKKPQIDSNK | 1161 | Q14571 | |
| QKQKRKTGTKPSTEP | 641 | Q96NI6 | |
| PGKVSSQKQPAEKAT | 576 | Q5JPF3 | |
| NSRVKPGFPKTIKTN | 31 | O76096 | |
| SQRAAKNGPPVSDQK | 871 | Q13469 | |
| SGAVPTNLKPSKIKQ | 301 | P78559 | |
| KDVPNTQPKAAFKSQ | 101 | Q9Y5V3 | |
| TQPKAAFKSQNATPK | 106 | Q9Y5V3 | |
| LIQGKARSAPKPSQA | 106 | Q9H6Y5 | |
| SRNIPGKVKVSAPNL | 1056 | O60524 | |
| KPQRDSQAQKSPVKS | 196 | Q9NQ76 | |
| NKVKSDPQKAVDQPR | 121 | O95983 | |
| GGKDKKQIQTSPVPV | 566 | Q9NRM7 | |
| KNQNAPPATRIEKKC | 511 | Q86WG5 | |
| ANQKPPSAEFKVVKA | 5416 | Q03001 | |
| KNEGPQRKNKASPQS | 781 | Q9NQW6 | |
| DKINGKPVDVKNPSV | 661 | Q8WW38 | |
| KPLKKQNPSSGARLN | 481 | Q9HDC5 | |
| KNGQAAQAPSTPAKR | 681 | Q8IWQ3 | |
| SVKKPDPNIKNNAAS | 411 | O43237 | |
| KAEPPKQQSSPLVNK | 706 | Q9BRR8 | |
| EVQATPNKAGPKLKD | 1111 | Q9UKJ3 | |
| FAQGQKNRVKPPKES | 341 | Q9UIW2 | |
| NKKPIGQVKPDLTSQ | 211 | Q1MSJ5 | |
| RPLGPNQTTSKSKNK | 196 | O60669 | |
| QAKEENASKPTPAKV | 631 | Q8IZD2 | |
| NASKPTPAKVNRTKQ | 636 | Q8IZD2 | |
| NPPSGSVRKTRKNKQ | 66 | Q15014 | |
| QDKVKAQEPVKGPVS | 56 | P19957 | |
| KNVTNKAASGPKRTP | 686 | Q6ZVL6 | |
| NLKVAKNGSKLPPAS | 451 | Q3SXY7 | |
| KPGKNKRTAITTPNF | 171 | Q9BXS6 | |
| ENEKPAKEQRQTPGK | 391 | P78316 | |
| KISQRDPSPESNKKG | 256 | Q8NDX5 | |
| SKPTKVAKVPAVNNV | 851 | O15265 | |
| PEKRKNSTQPEKESN | 1416 | Q7Z6E9 | |
| PSRNKDSASGQKNKP | 1501 | Q7Z6E9 | |
| ISKQANKAKPAPRTQ | 31 | Q75N03 | |
| PTPQFGQRTTKSKKK | 806 | Q96MT3 | |
| PPASSAKVNKIVKNR | 81 | O00139 | |
| DPNKQTPSGKKCIAA | 841 | Q01780 | |
| KTGPQLAPRKDKSQT | 561 | Q05DH4 | |
| PEQKEQSTGQKRPLK | 981 | Q9Y4L1 | |
| SEEQPSGNGVKKPKI | 116 | Q9H4Z3 | |
| VSTKKPNVKGIFPAN | 46 | Q8IZD9 | |
| KNQLNKETDPVKSPP | 96 | Q96JM3 | |
| PVTPNKQKTDGRGTK | 136 | Q7Z7M9 | |
| PQSEKVSKQGLPAEK | 386 | P48165 | |
| GDSQPNKSIRNLKPK | 1446 | Q9NSI6 | |
| KLPDAAAKSKPQQSA | 246 | Q86TE4 | |
| TEDQPAQEKKSPKGQ | 606 | Q96JA4 | |
| KPEPTNQGQDSLKKR | 26 | Q96DS6 | |
| ESGPEQSKQKKVAPR | 1336 | Q03164 | |
| EKTISKAKGQPREPQ | 216 | P01857 | |
| RNTPAKSENVDVGKP | 2011 | Q8WYP5 | |
| KNPSGKNRETVPIKD | 96 | Q8WXE1 | |
| NKGDAREKKPASPQV | 531 | Q6ZVF9 | |
| QARKVNKRKSPPGSN | 346 | Q8NCQ7 | |
| SPQKQIRDFKPSKQA | 936 | Q08AD1 | |
| NIKKAGFQKPTPIQS | 256 | Q9NXZ2 | |
| AQPQPTGEKEQDKSK | 211 | Q14154 | |
| TKLGPDDPNVAKTKN | 371 | Q07866 | |
| NITDGPAKENPNEKK | 56 | A0A1B0GVS7 | |
| EGSAQAPQLPRKKDK | 461 | Q9Y4K4 | |
| AISPKPQSQKKNEAD | 311 | A8MW92 | |
| KQQNSPLAKSKPGST | 531 | Q8N4C8 | |
| AKRNKVSQEQSKPPG | 146 | P41218 | |
| KNPPEGKRKLSQNET | 851 | Q10571 | |
| QQKAEATEPLKSAKP | 156 | P49848 | |
| NNKKPKTSGSQDSQP | 31 | Q02446 | |
| PPSKRKVTTKIQGNA | 166 | Q8NF91 | |
| QAKPSGKAPQVRAAS | 426 | Q13428 | |
| KKTQAKANPAAARAP | 786 | Q13428 | |
| QKQNLTKIPPRGKSS | 796 | O14513 | |
| TPQKNVQGKRKISPS | 506 | P35251 | |
| NTQGLKSPENPKKAA | 66 | Q8N6K7 | |
| PSKNAPKDQTVSQKE | 91 | Q5K651 | |
| QNGKKATSKVPSAPH | 31 | Q9NVN8 | |
| KPAPVTAESQKTVKN | 1181 | Q8IWB4 | |
| KTNGPLKQKQPSFSA | 76 | Q9NZH4 | |
| PFSDPKKQVDTNTKN | 1471 | O60292 | |
| KNFQKVPDQKGTPKR | 41 | Q8N8I0 | |
| KVSQKKQRGRPSSQP | 31 | Q99865 | |
| VPTKIQKGPDNTKAR | 146 | A0A087WV53 | |
| KTNGPRKQKQPSFSA | 76 | Q9NZH5 | |
| KSGFSQHQNKSPPKV | 296 | Q96QB1 | |
| PKNVNLKKDSENTPV | 386 | Q92922 | |
| SQEQVAQKLAKDPKP | 171 | Q5JPH6 | |
| KPNGRNVPVTEENKK | 571 | Q9HCE7 | |
| PPGKANISEKINKRS | 141 | Q16384 | |
| QDVSGQLNSTKKPPK | 741 | P25440 | |
| AQTKREVPKNKAPTA | 1446 | P25054 | |
| PTPVNNNTKKRDSKT | 2806 | P25054 | |
| KNPKVAEIPFNSTNK | 481 | Q13733 | |
| KPQKAVQPKHEVGTR | 51 | Q8TAZ6 | |
| RKKEQPKSSQANPGR | 161 | P42695 | |
| SPVQGGDPSENKKKV | 431 | Q9Y6X2 | |
| SKPPSPKQNVRKNLD | 291 | Q9P2M4 | |
| KPAPVTAESQKTVKN | 1181 | Q5VYP0 | |
| KDVPNKSGADGQTPK | 176 | O43493 | |
| QTPKDVPNKSGAEKQ | 201 | O43493 | |
| VPNKSGAEKQTPKDG | 206 | O43493 | |
| TANGASKEKTKAPPN | 1176 | Q9UHF7 | |
| KNPKTQLGQKPFTCS | 211 | P13682 | |
| SVGEKAHKEKPNQPA | 26 | Q9BZV1 | |
| SCKAKVQPPRLNGAK | 96 | Q9BU70 | |
| QNVVIKVKPPSKSGS | 121 | Q8IXZ2 | |
| PTEEPSQGAQATKKK | 251 | Q96EK2 | |
| KPAPVTAESQKTVKN | 1181 | Q5TZJ5 | |
| RKGSVCADPKPQQVK | 61 | Q96MK2 | |
| KPAPVTAESQKTVKN | 1181 | Q5VU36 | |
| ITAASKKAPAQKVPA | 166 | P50914 | |
| KQRGKKAVPVESPVQ | 416 | Q8TB61 | |
| KVSQKKQRGRPSSQP | 31 | Q9BPZ2 | |
| QKNDPKKAPVARSSV | 366 | P42331 | |
| SQEKRKIPAVPNGTA | 446 | Q6U841 | |
| QKTKGTSKLVDNRPP | 1521 | Q92545 | |
| AIQPKESNIPKSSAK | 141 | Q86VQ3 | |
| LGNIAKTSVKPSQPK | 221 | Q86VQ3 | |
| RKDKFNPVNQPKESS | 811 | Q9UBT6 | |
| PPKQKGRVASQCQTA | 1926 | Q9HCK1 | |
| TNVKKAKRPKPESQG | 216 | Q9Y2X9 | |
| QKVARVKAPNKSLPS | 656 | O43290 | |
| QPKPKQKGRSSTASL | 551 | O15213 | |
| QTSDQKKVLKNPPAG | 666 | Q9H6S0 | |
| STGFPKPNSQVKELK | 181 | Q6NX49 | |
| NQEEKKTPSKPPAQL | 251 | P18887 | |
| PGKDADQTPAKTKNL | 336 | Q5QJ38 | |
| KQRKAPAPQRTKAGS | 466 | Q01831 | |
| KVNQQPNTSDKKSSP | 381 | P54578 | |
| VPTAGPLAQKRNQKA | 601 | Q96LC7 | |
| TFTQKISKPGEAPKN | 951 | Q8IWV8 | |
| PKQKESLRGSIPAAQ | 846 | Q5VUA4 | |
| QTSGEAKDGPPKKQV | 356 | Q96GM8 | |
| KNKDSNKPVTIPENS | 851 | Q14966 | |
| KKNGAAKQSNPKSSP | 6 | P40222 | |
| LKEKQAPRNASKPSS | 486 | Q70EL1 | |
| AKLEPKRTGTSKQNP | 226 | Q9C0D4 | |
| NKASKQDPPTDQGDK | 436 | Q496Y0 |